Dermatitis due to substances taken internally

L12_INTERNALSUBSTANCEDERM

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L27 Hospital discharge: ICD-9 — 693 Hospital discharge: excluded ICD-10 — L27.2 Cause of death: ICD-10 — L27 Cause of death: ICD-9 — 693 Cause of death: excluded ICD-10 — L27.2 2 out of 7 registries used, show all original rules.	2632
4. Check minimum number of events None	2632
5. Include endpoints None	2632
6. Filter based on genotype QC (FinnGen only)	2338

Control definitions (FinnGen only)

Control exclude: L12_DERMATITISECZEMA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF12
Parent code in ICD-10: L20-L30
Name in latin: Dermatitis e substantiis devoratis

NAME	L12_INTERNALSUBSTANCEDERM
CONTROL_EXCLUDE	L12_DERMATITISECZEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L27
HD_ICD_9	693
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL	L272
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L27
COD_ICD_9	693
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL	L272
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dermatitis due to substances taken internally based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2338	1493	845
Unadjusted period prevalence (%)	0.48	0.53	0.39
Median age at first event (years)	53.66	50.77	58.76

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2403: Matched controls
24030

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

1316.5

307.7

1610

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

9.8

307.7

563

724

XQ802

NOMESCO Finland

Epicutan test

31.2

307.7

242

L27.1

ICD-10 Finland

Localized skin eruption due to drugs and medicaments

282.7

307.7

458

XQ800

NOMESCO Finland

Prick test

8.0

275.6

413

607

L30.9

ICD-10 Finland

Dermatitis, unspecified

4.9

256.3

737

2000

L20.0

ICD-10 Finland

Besnier prurigo

+∞

252.7

238

H02AB06

ATC

prednisolone; systemic

4.1

235.8

1586

7779

E0000UV, ,

ATC

3.4

189.7

1297

6156

XQ820

NOMESCO Finland

Exposure to medicinal substance

42.6

176.4

106

D07AC01

ATC

betamethasone; topical

3.3

176.1

1098

4877

D07AB08

ATC

desonide; topical

5.1

175.5

421

963

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

5.4

169.0

370

781

R06AE07

ATC

cetirizine; oral

3.0

151.4

1382

7445

6930B

ICD-9 Finland

Dermatitis due to substances taken internally, Due to drugs and medicines[EXANTHEMA EX USU PHARMACIS]

+∞

144.2

137

XQ899

NOMESCO Finland

Other assessment of skin

39.4

130.6

D07AA02

ATC

hydrocortisone; topical

3.7

128.8

487

1547

L50.0

ICD-10 Finland

Allergic urticaria

7.7

124.8

181

251

J01FF01

ATC

clindamycin; systemic

2.8

121.5

860

3936

T78.4

ICD-10 Finland

Allergy, unspecified

5.7

118.9

234

444

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

+∞

115.6

110

XQ801

NOMESCO Finland

Intracutantest

25.5

112.7

E000001, ,

ATC

3.1

111.0

602

2368

D07AB02

ATC

hydrocortisone butyrate; topical

2.7

110.8

839

3943

TQW80

NOMESCO Finland

Local dermatologic skincare

10.8

100.5

110

106

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

7.7

98.1

141

193

C01CA24

ATC

epinephrine; parenteral

4.3

96.6

271

690

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.4

96.3

1308

7947

D07BA04

ATC

hydrocortisone and antiseptics; topical

3.6

93.9

344

1057

R50.9

ICD-10 Finland

Fever, unspecified

2.9

90.8

536

2185

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

53.1

90.8

L27.2

ICD-10 Finland

Dermatitis due to ingested food

911.7

90.4

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

16.0

84.8

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

8.2

83.9

113

143

D07AC13

ATC

mometasone; topical

2.5

83.1

739

3667

L50.9

ICD-10 Finland

Urticaria, unspecified

4.9

80.3

184

397

6939X

ICD-9 Finland

Dermatitis due to substances taken internally, Due to unspecified substance taken internally

+∞

78.6

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

3.0

76.1

379

1397

E000002, ,

ATC

3.3

75.8

318

1059

D07AD01

ATC

clobetasol; topical

2.8

74.6

449

1833

D02AX

ATC

Other emollients and protectives

6.7

72.6

117

181

L20

ICD-10 Finland

Atopic dermatitis

+∞

71.2

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.0

70.5

360

1342

6931A

ICD-9 Finland

Dermatitis due to substances taken internally, Due to food

+∞

70.1

L27.9

ICD-10 Finland

Dermatitis due to unspecified substance taken internally

+∞

65.9

J01MA12

ATC

levofloxacin; systemic

2.5

64.9

520

2426

L30.3

ICD-10 Finland

Infective dermatitis

8.2

64.6

110

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

+∞

63.8

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

4.2

60.5

169

426

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

59.1

422

1859

E000006, ,

ATC

3.7

58.0

199

580

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

57.0

884

5342

L04AX03

ATC

methotrexate; systemic

2.8

55.7

311

1210

A46

ICD-10 Finland

Erysipelas

2.5

55.0

394

1734

R06AX27

ATC

desloratadine; oral

2.0

54.4

780

4565

E000003, ,

ATC

4.5

53.7

134

309

L04AX01

ATC

azathioprine; systemic

4.0

53.1

157

412

J01MA02

ATC

ciprofloxacin; systemic

2.0

53.0

960

6087

H02AB04

ATC

methylprednisolone; systemic

2.5

51.9

394

1779

ZX108

NOMESCO Finland

Inhalation

11.5

51.0

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

50.8

742

4351

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

+∞

50.2

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.7

49.1

161

454

H02AB07

ATC

prednisone; oral

2.4

46.7

368

1684

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.5

46.7

323

1393

A02BC02

ATC

pantoprazole; systemic

1.9

46.1

1639

12705

N05BB01

ATC

hydroxyzine; systemic

3.3

46.0

188

611

R06AE09

ATC

levocetirizine; oral

2.3

45.7

392

1860

N02AX02

ATC

tramadol; systemic, rectal

1.9

45.4

1024

6878

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.5

45.0

331

1467

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

44.8

658

3840

J01DB01

ATC

cefalexin; oral

2.2

43.9

2003

16754

D11AH01

ATC

tacrolimus; topical

95.9

42.9

P01BA02

ATC

hydroxychloroquine; oral

2.7

42.4

244

959

XQ848

NOMESCO Finland

Dermatological photography

5.0

42.1

190

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.0

41.7

543

3026

D07XC01

ATC

betamethasone; topical

2.5

41.2

287

1238

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.3

41.2

163

519

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

39.8

494

2701

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

39.0

588

3439

N02AA05

ATC

oxycodone; systemic

2.1

38.8

456

2442

L04AD01

ATC

ciclosporin; systemic

5.5

38.7

139

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

38.3

561

3245

J01MA14

ATC

moxifloxacin; systemic

2.6

37.9

243

1006

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

4.2

37.7

104

259

J01DA01

ATC

[U] cefalexin

1.8

37.6

1462

11287

C03CA01

ATC

furosemide; systemic

1.9

37.6

687

4267

N03AX16

ATC

[U] pregabalin

1.9

37.6

554

3209

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.5

37.6

254

1079

L30.8

ICD-10 Finland

Other specified dermatitis

5.4

37.6

143

R03BA02

ATC

budesonide; inhalant

2.0

37.0

466

2554

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

36.1

490

2756

D07BC01

ATC

betamethasone and antiseptics; topical

2.4

35.9

266

1178

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.3

35.8

141

447

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

6.9

35.7

D02AE01

ATC

carbamide; topical

3.0

34.8

158

545

L40.0

ICD-10 Finland

Psoriasis vulgaris

3.6

34.6

119

346

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.7

34.3

111

310

D07CC01

ATC

betamethasone and antibiotics; topical

2.3

34.2

291

1367

N03AG01

ATC

valproic acid; systemic, rectal

2.8

34.2

181

680

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

10.7

34.0

L50.8

ICD-10 Finland

Other urticaria

5.0

33.9

149

JN4AD

NOMESCO Finland

Body CT examination

2.3

33.4

295

1407

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

33.4

330

1648

L04AA06

ATC

mycophenolic acid; systemic

5.0

33.3

151

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.6

33.2

197

784

J01FA06

ATC

roxithromycin; oral

1.7

32.9

925

6456

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

11.1

32.9

ZX120

NOMESCO Finland

Intravenous

2.4

32.9

255

1151

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

32.7

560

3388

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

32.6

650

4116

R03AC02

ATC

salbutamol; inhalant

1.7

32.0

1319

10148

R03DC03

ATC

montelukast; oral

2.0

31.7

424

2362

A04AA01

ATC

ondansetron; systemic, rectal

2.4

31.4

231

1017

6930A

ICD-9 Finland

Dermatitis due to substances taken internally, Due to drugs and medicines[ECZEMA EX USU PHARMACIS]

+∞

31.3

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.9

31.2

153

551

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

316.9

30.9

J01AA02

ATC

doxycycline; systemic

1.7

30.4

1775

14866

D11AH02

ATC

pimecrolimus; topical

+∞

30.3

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

4.1

30.2

206

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.0

30.0

225

A92

ICPC

Allergy/allergic reaction NOS

3.4

29.8

112

345

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

29.6

977

7056

D09AB01

ATC

zinc bandage without supplements; topical

6.4

29.1

D05BB02

ATC

acitretin; oral

4.7

29.0

149

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.5

28.9

201

862

J02AC01

ATC

fluconazole; systemic

1.6

28.9

923

6602

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

28.9

891

6317

L30.0

ICD-10 Finland

Nummular dermatitis

4.0

28.8

209

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

28.7

539

3335

N03AX12

ATC

[U] gabapentin; oral

2.0

28.7

380

2104

S88

ICPC

Dermatitis contact/allergic

4.3

28.7

175

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.5

28.4

188

788

S01GX01

ATC

cromoglicic acid; ophthalmic

1.8

28.1

487

2940

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

28.1

483

2909

R06.0

ICD-10 Finland

Dyspnoea

1.7

28.0

636

4153

R01AD08

ATC

fluticasone; nasal

1.7

28.0

673

4463

H02AB02

ATC

dexamethasone; systemic

2.1

28.0

297

1519

M04AA01

ATC

allopurinol; systemic

2.1

28.0

294

1498

J05AB01

ATC

aciclovir; systemic

1.8

27.8

530

3292

UJF32

NOMESCO Finland

Coloscopy

1.7

27.7

581

3707

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

27.2

247

1188

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

27.2

265

1311

R06AX13

ATC

loratadine; oral

1.9

27.2

367

2044

L26

ICD-10 Finland

Exfoliative dermatitis

+∞

27.1

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

27.1

390

2219

R01AD09

ATC

mometasone; nasal

1.6

27.1

1062

7952

P01AB01

ATC

metronidazole; oral, rectal

1.6

27.1

926

6709

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

26.5

417

2439

J05AB11

ATC

valaciclovir; oral

1.9

26.2

356

1985

L20.8

ICD-10 Finland

Other atopic dermatitis

+∞

26.1

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

26.0

345

1907

WZC30

NOMESCO Finland

Teaching

1.9

26.0

392

2261

M79.6

ICD-10 Finland

Pain in limb

1.6

25.9

1021

7629

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.4

25.9

180

772

XG410

NOMESCO Finland

Flow-volume spirometry

3.1

25.5

110

368

N03AF01

ATC

carbamazepine; oral, rectal

2.8

25.5

136

512

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

25.3

313

1690

D11AX14

ATC

[U] tacrolimus

+∞

25.0

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.0

24.9

111

JN4BD

NOMESCO Finland

Extensive body CT

2.2

24.8

237

1163

R60.0

ICD-10 Finland

Localized oedema

2.0

24.7

296

1579

GD1AD

NOMESCO Finland

Thorax CT examination

2.5

24.6

162

677

H02AB09

ATC

hydrocortisone; systemic

3.6

24.6

234

R06AX22

ATC

ebastine; oral

1.8

24.5

395

2323

R03BA05

ATC

fluticasone; inhalant

1.8

24.5

437

2652

J01XX08

ATC

linezolid; systemic

8.0

24.3

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.4

24.2

167

713

N02BE01

ATC

paracetamol; systemic, rectal

1.9

24.1

2093

18765

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

+∞

24.0

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

23.9

459

2843

N05CF01

ATC

zopiclone; oral

1.6

23.6

708

4932

R03AC03

ATC

terbutaline; inhalant

1.9

23.5

325

1819

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.6

23.5

217

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

23.5

470

2945

J01FA10

ATC

azithromycin; systemic

1.5

23.5

1363

11022

AA1AD

NOMESCO Finland

CT of head and brain

1.6

23.4

640

4357

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

7.3

23.3

J01FA09

ATC

clarithromycin; systemic

1.6

23.2

712

4982

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.6

23.1

224

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

23.1

256

1326

L01BA01

ATC

methotrexate; systemic

3.0

23.1

106

368

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

3.9

23.1

178

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

4.1

23.0

156

A03

ICPC

Fever

1.7

22.9

458

2867

A02BC05

ATC

esomeprazole; systemic

1.6

22.8

897

6642

N03AF02

ATC

oxcarbazepine; oral

3.1

22.8

328

XW000

NOMESCO Finland

Bone marrow biopsy

2.8

22.5

114

418

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

45.5

22.4

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.1

22.3

240

1230

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

22.3

234

1189

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.0

22.2

165

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

22.0

314

1774

N03AX09

ATC

lamotrigine; oral

2.5

22.0

140

576

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.4

21.9

156

676

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.2

21.7

284

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

3.1

21.7

300

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.5

21.7

142

592

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

21.6

316

1798

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

21.6

875

6504

NF1AA

NOMESCO Finland

Hip X-ray examination

2.1

21.5

220

1107

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

21.4

960

7289

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.3

21.3

177

819

J01DA09

ATC

[U] cefadroxil

1.6

21.0

588

4009

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

20.9

282

1562

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

60.6

20.9

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

20.9

702

4997

A07EC01

ATC

sulfasalazine; oral, rectal

2.1

20.7

197

963

J46

ICD-10 Finland

Status asthmaticus

3.2

20.5

258

M54.5

ICD-10 Finland

Low back pain

1.5

20.4

840

6248

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

20.3

222

1143

SPAT1263

SPAT

Sampling

1.5

20.3

956

7313

J01FA01

ATC

erythromycin; systemic

1.8

20.3

330

1940

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

20.2

968

7429

ZYC01

NOMESCO Finland

Remote contact by phone

2.3

20.1

165

760

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

20.0

959

7357

N03AX14

ATC

levetiracetam; systemic

3.1

19.9

278

L27.8

ICD-10 Finland

Dermatitis due to other substances taken internally

+∞

19.8

D70.82

ICD-10 Finland

Drug-induced neutropenia

4.3

19.8

121

E000007, ,

ATC

2.7

19.7

109

418

R02

ICPC

Shortness of breath/dyspnoea

1.8

19.7

317

1856

R51.80

ICD-10 Finland

Headache

1.7

19.7

391

2433

L04AA01

ATC

[U] ciclosporin

4.8

19.7

S29

ICPC

Skin symptom/complaint other

1.7

19.5

458

2980

WW500

NOMESCO Finland

Blood transfusion

2.6

19.4

111

433

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

19.4

190

939

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

19.2

252

1382

L51.9

ICD-10 Finland

Erythema multiforme, unspecified

16.9

19.2

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.3

19.0

223

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.7

19.0

101

380

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

3.0

19.0

286

B01AB05

ATC

enoxaparin; parenteral

1.5

18.9

673

4832

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.8

18.6

149

A02BC03

ATC

lansoprazole; oral

1.6

18.6

604

4246

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.7

18.6

163

S76

ICPC

Skin infection other

2.4

18.5

132

573

TGC00

NOMESCO Finland

Bronchial lavation

3.4

18.4

203

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

18.3

220

1171

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

18.3

562

3899

S18

ICPC

Laceration/cut

1.5

18.2

1027

8093

N06AX21

ATC

duloxetine; oral

1.8

18.0

277

1599

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

17.9

173

851

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

17.9

403

2591

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.7

17.8

375

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

17.8

1202

9791

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

37.0

17.6

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

17.6

146

676

A07AA02

ATC

nystatin; oral

2.3

17.6

135

605

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

7.8

17.4

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.3

17.3

132

589

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.3

17.2

128

565

SPAT1260

SPAT

Consultation of another employee

1.7

17.2

381

2435

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.8

17.1

278

1630

S97

ICPC

Chronic ulcer skin

2.2

17.1

140

645

SPAT1153

SPAT

Removal of sutures

1.5

17.0

651

4731

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

16.7

161

790

L03AA02

ATC

filgrastim; parenteral

2.9

16.7

285

M13.9

ICD-10 Finland

Arthritis, unspecified

2.1

16.6

174

881

M79.1

ICD-10 Finland

Myalgia

1.7

16.6

356

2254

N05BA01

ATC

diazepam; systemic, rectal

1.8

16.6

286

1705

R01AD12

ATC

fluticasone furoate; nasal

1.5

16.6

708

5256

SPAT1301

SPAT

No procedures

1.5

16.5

679

5004

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.5

16.4

106

439

ZX112

NOMESCO Finland

Subcutaneous

3.3

16.4

187

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

16.4

201

1076

J45.8

ICD-10 Finland

Mixed asthma

2.9

16.4

271

L51.0

ICD-10 Finland

Nonbullous erythema multiforme

23.2

16.4

Z51.5

ICD-10 Finland

Palliative care

2.0

16.4

190

998

ZXD05

NOMESCO Finland

Urgent procedure

1.5

16.4

657

4812

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.0

16.4

239

N05BA04

ATC

oxazepam; oral

1.5

16.4

592

4244

N02BF02

ATC

pregabalin; oral

2.1

16.3

161

798

C07AB07

ATC

bisoprolol; oral

1.4

16.3

985

7814

L04AA13

ATC

[U] leflunomide

3.1

16.3

219

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

16.2

552

3905

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

3.3

16.2

184

S87

ICPC

Dermatitis/atopic eczema

3.6

16.1

150

J45

ICD-10 Finland

Asthma

1.9

16.1

232

1310

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

3.8

16.1

127

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

16.1

307

1884

SPAT1255

SPAT

Intravenous administration of medicine

2.1

16.1

153

748

L50

ICD-10 Finland

Urticaria

3.3

16.0

180

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

15.9

647

4747

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

4.4

15.9

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

14.6

15.8

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

15.8

347

2212

127

Kela drug reimbursment

Transplant complication

3.9

15.7

120

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.9

15.7

261

E930A

ICD-9 Finland

Antibiotics[PENISILLIINIT]

33.6

15.7

L04AX04

ATC

lenalidomide; oral

5.9

15.7

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.4

15.7

108

461

L29.9

ICD-10 Finland

Pruritus, unspecified

3.3

15.6

178

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

15.6

129

597

L30

ICD-10 Finland

Other dermatitis

3.2

15.5

194

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

15.4

307

1907

SPAT1229

SPAT

Assessment of need for aid

2.0

15.4

164

837

WW200

NOMESCO Finland

Immunization

2.9

15.3

254

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

4.1

15.2

105

M25.5

ICD-10 Finland

Pain in joint

1.5

15.2

726

5491

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

15.1

599

4368

A04AA02

ATC

granisetron; systemic, transdermal

2.1

15.1

151

753

L40.5

ICD-10 Finland

Arthropathic psoriasis

3.6

15.1

138

N03AX18

ATC

lacosamide; systemic

5.0

15.0

L04AB04

ATC

adalimumab; parenteral

3.0

14.9

225

T78.3

ICD-10 Finland

Angioneurotic oedema

4.2

14.9

R53

ICD-10 Finland

Malaise and fatigue

1.5

14.8

575

4170

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

14.8

128

603

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.5

14.7

150

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

3.1

14.6

201

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.1

14.6

140

687

D05AX52

ATC

calcipotriol, combinations; topical

2.4

14.6

105

458

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.2

14.5

176

J20

ICD-10 Finland

Acute bronchitis

1.8

14.5

236

1382

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.6

14.5

319

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

14.5

105

459

X57

ICD-10 Finland

Unspecified privation

3.1

14.5

197

Z88.1

ICD-10 Finland

Personal history of allergy to other antibiotic agents

150.9

14.5

A41.9

ICD-10 Finland

Sepsis, unspecified

2.6

14.5

337

A02BC01

ATC

omeprazole; systemic

1.5

14.4

574

4183

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.6

14.3

133

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.5

14.3

681

5138

L17

ICPC

Foot/toe symptom/complaint

1.5

14.2

673

5069

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

14.2

402

2719

R11

ICD-10 Finland

Nausea and vomiting

1.8

14.2

220

1269

R96

ICPC

Asthma

1.8

14.2

220

1270

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

14.2

187

1026

395

Kela drug reimbursment

Dupilumab

42.7

14.1

SPAT1254

SPAT

Administration of medicine

1.6

14.1

341

2224

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

14.0

138

683

D07XB05

ATC

dexamethasone; topical

3.1

13.9

186

J01EA01

ATC

trimethoprim; systemic

1.5

13.9

569

4165

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

13.9

190

1056

L71.9

ICD-10 Finland

Rosacea, unspecified

2.9

13.8

235

A07EA06

ATC

budesonide; oral, local oral

2.5

13.8

375

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

13.8

858

6786

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

13.7

146

744

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

13.7

225

1321

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.3

13.7

101

445

S06

ICPC

Rash localized

2.1

13.6

130

636

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

4.3

13.6

WX002

NOMESCO Finland

Sedation and analgesia

1.6

13.5

390

2649

L16

ICPC

Ankle symptom/complaint

1.7

13.4

283

1782

UKC02

NOMESCO Finland

Cystoscopy

1.6

13.3

295

1879

R42

ICD-10 Finland

Dizziness and giddiness

1.5

13.3

486

3472

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

13.3

138

697

D07AC14

ATC

methylprednisolone aceponate; topical

2.4

13.3

376

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

10.5

13.2

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

13.2

222

1313

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

13.2

1163

9728

E000004, ,

ATC

3.7

13.0

113

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

13.0

123

600

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

13.0

205

1189

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

3.8

13.0

104

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

5.2

13.0

D11AH05

ATC

dupilumab; topical

28.5

13.0

SPAT1325

SPAT

Vaccination

1.4

13.0

701

5396

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

12.9

260

1615

UDC00

NOMESCO Finland

Ear microscopy

1.9

12.9

166

903

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

12.9

350

2343

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

11.6

12.8

A10AB05

ATC

insulin aspart; parenteral

1.9

12.7

169

930

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.5

12.7

341

L03AA13

ATC

pegfilgrastim; parenteral

2.2

12.6

105

488

D11AX15

ATC

[U] pimecrolimus

+∞

12.5

R03AC12

ATC

salmeterol; inhalant

2.3

12.5

418

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.5

12.5

307

153

Kela drug reimbursment

Lenalidomid

5.3

12.5

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

12.5

211

1250

G47.3

ICD-10 Finland

Sleep apnoea

1.5

12.4

439

3110

R01AD58

ATC

fluticasone, combinations; nasal

1.5

12.4

548

4058

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

12.4

587

4405

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

12.4

589

4425

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

3.2

12.3

147

D07AB01

ATC

clobetasone; topical

2.7

12.3

256

B35.3

ICD-10 Finland

Tinea pedis

2.2

12.3

101

466

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

4.1

12.3

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

12.3

223

1347

L28.0

ICD-10 Finland

Lichen simplex chronicus

14.4

12.3

K30

ICD-10 Finland

Functional dyspepsia

1.7

12.3

247

1535

N02BF01

ATC

gabapentin; oral

1.7

12.2

225

1364

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

12.2

133

684

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.6

12.2

263

N05BA09

ATC

clobazam; oral

5.1

12.2

S21

ICPC

Skin texture symptom/complaint

1.6

12.2

314

2074

A10AC01

ATC

insulin (human); parenteral

1.9

12.2

163

899

R03AK08

ATC

formoterol and beclometasone; inhalant

2.2

12.1

101

469

L40.9

ICD-10 Finland

Psoriasis, unspecified

3.6

12.1

114

N06AX16

ATC

venlafaxine; oral

1.6

12.1

309

2037

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

12.0

256

1613

A02BA02

ATC

ranitidine; systemic

1.5

12.0

374

2578

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

12.0

223

1355

D69.0

ICD-10 Finland

Allergic purpura

5.3

12.0

M03BX02

ATC

tizanidine; oral

1.4

12.0

1307

11237

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.0

11.9

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.3

11.9

401

212

Kela drug reimbursment

Gout

3.3

11.9

135

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

11.9

290

1890

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

11.8

218

1324

N06AX11

ATC

mirtazapine; oral

1.4

11.8

719

5635

L50.1

ICD-10 Finland

Idiopathic urticaria

4.9

11.7

L50.3

ICD-10 Finland

Dermatographic urticaria

3.4

11.7

122

C91.4

ICD-10 Finland

Hairy-cell leukaemia

30.2

11.6

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.1

11.6

158

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

11.6

169

958

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

11.6

309

2058

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.1

11.6

153

L51.1

ICD-10 Finland

Bullous erythema multiforme

23.0

11.6

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

3.8

11.5

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

11.5

225

1388

6929X

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]

+∞

11.5

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

11.5

379

2646

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.4

11.4

308

L24.0

ICD-10 Finland

Irritant contact dermatitis due to detergents

120.6

11.4

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.6

11.4

249

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

11.4

403

H03AA01

ATC

levothyroxine sodium; systemic

1.5

11.4

485

3562

L40.8

ICD-10 Finland

Other psoriasis

5.4

11.3

D01AC02

ATC

miconazole; topical

1.9

11.3

146

796

J01FA15

ATC

telithromycin; oral

1.7

11.3

201

1208

9940/3-C42.1

ICD-O-3

Hairy cell leukemia, NOS, of bone marrow

35.2

11.3

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

4.9

11.2

M01AE02

ATC

naproxen; oral, rectal

1.3

11.2

1246

10696

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.7

11.2

190

1126

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

11.1

100

479

134

Kela drug reimbursment

General erythroderma

12.8

11.1

A06AD11

ATC

lactulose; oral

1.6

11.1

292

1937

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

3.6

11.1

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

8.1

11.1

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

11.1

520

3886

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.3

11.1

344

WX892

NOMESCO Finland

Monitored bed care

1.8

11.1

156

875

C10AC01

ATC

colestyramine; oral

2.6

11.1

241

XCK00

NOMESCO Finland

Perimetry

2.0

11.1

119

610

N18.8

ICD-10 Finland

Other chronic renal failure

3.0

11.0

168

C08CA01

ATC

amlodipine; oral

1.4

11.0

733

5811

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.8

11.0

190

L88

ICPC

Rheumatoid/seropositive arthritis

2.2

11.0

441

SPAT1312

SPAT

General health counselling

1.4

11.0

686

5381

D06AX01

ATC

fusidic acid; topical

1.7

11.0

196

1177

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

11.0

438

3172

ZXE00

NOMESCO Finland

One hour or less

1.4

11.0

817

6592

J01CE08

ATC

benzathine benzylpenicillin; parenteral

4.5

11.0

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

43.5

10.9

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.0

10.9

164

L01BB02

ATC

mercaptopurine; oral

3.5

10.9

103

A04

ICPC

Weakness/tiredness general

1.5

10.8

363

2539

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

10.8

186

1106

R03BA01

ATC

beclometasone; inhalant

1.6

10.8

278

1834

S02

ICPC

Pruritus

2.3

10.8

354

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

10.8

151

845

Z3231

NOMESCO Finland

Registered nurse

1.4

10.8

552

4187

L28

ICPC

Limited function/disability (L)

1.5

10.8

378

2670

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

10.7

239

1524

A03FA02

ATC

cisapride; oral, rectal

1.8

10.7

152

855

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.9

10.6

172

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

10.6

276

1828

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.2

10.6

416

L93.0

ICD-10 Finland

Discoid lupus erythematosus

8.5

10.5

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

10.5

1186

10166

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

10.5

152

860

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.0

10.5

157

N03AE01

ATC

clonazepam; systemic

2.0

10.5

115

594

Z51.6

ICD-10 Finland

Desensitization to allergens

3.5

10.4

101

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.9

10.4

125

665

M05BX04

ATC

denosumab; parenteral

1.9

10.4

131

708

Z00.0

ICD-10 Finland

General medical examination

1.5

10.4

410

2960

TK800

NOMESCO Finland

Hemodialysis

3.0

10.4

147

H01

ICPC

Ear pain/earache

1.6

10.4

267

1762

B03XA02

ATC

darbepoetin alfa; parenteral

2.8

10.3

180

A11CC03

ATC

alfacalcidol; systemic

2.7

10.3

197

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.2

10.3

374

A01AB09

ATC

miconazole; local oral

1.7

10.3

176

1045

ZY010

NOMESCO Finland

Hospital outpatient

1.9

10.3

122

647

Z71.8

ICD-10 Finland

Other specified counselling

1.4

10.3

751

6031

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

10.3

125

669

R74

ICPC

Upper respiratory infection acute

1.4

10.3

754

6060

L04AB01

ATC

etanercept; parenteral

3.0

10.2

143

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.5

10.2

257

L01

ICPC

Neck symptom/complaint

1.5

10.2

362

2561

183

Kela drug reimbursment

Lamotrigin and topiramate

4.1

10.2

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.3

10.1

118

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

10.0

181

1091

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

10.0

192

1176

H66.9

ICD-10 Finland

Otitis media, unspecified

1.8

10.0

163

954

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.8

10.0

S06.0

ICD-10 Finland

Concussion

1.6

10.0

234

1509

137

Kela drug reimbursment

Uraemia requiring dialysis

4.6

10.0

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

10.0

269

1793

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.3

10.0

109

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

10.0

419

M01AH05

ATC

etoricoxib; oral

1.3

10.0

1292

11257

R03AC13

ATC

formoterol; inhalant

2.0

10.0

101

507

Z94.0

ICD-10 Finland

Kidney transplant status

3.9

9.9

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

4.2

9.9

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

9.9

157

913

Z01.2

ICD-10 Finland

Dental examination

1.3

9.9

1034

8742

S01

ICPC

Pain/tenderness of skin

2.0

9.9

103

523

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

4.3

9.8

D05AX02

ATC

calcipotriol; topical

2.3

9.8

305

L40.1

ICD-10 Finland

Generalized pustular psoriasis

26.1

9.8

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.5

9.8

232

B01AB10

ATC

tinzaparin; parenteral

1.6

9.8

223

1429

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

9.8

1611

14502

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.7

9.8

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

9.8

649

5128

J30.3

ICD-10 Finland

Other allergic rhinitis

2.2

9.7

364

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

9.7

258

1714

X58

ICD-10 Finland

Exposure to other specified factors

1.5

9.7

315

2187

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

9.7

133

740

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.0

9.6

104

534

B07.9

ICD-10 Finland

Verruca simplex

2.2

9.6

385

UDM02

NOMESCO Finland

Sinoscopy

2.7

9.6

193

C90.0

ICD-10 Finland

Multiple myeloma

3.5

9.6

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

9.6

830

6818

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.1

9.6

432

J32.4

ICD-10 Finland

Chronic pansinusitis

3.1

9.6

122

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.9

9.6

112

591

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

9.6

172

1036

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.9

9.6

149

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

9.6

253

1680

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

9.5

268

1803

D05AX03

ATC

calcitriol; topical

3.6

9.5

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

9.5

301

2077

L04AC05

ATC

ustekinumab; parenteral

7.2

9.5

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

9.5

165

986

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.1

9.5

408

R55

ICD-10 Finland

Syncope and collapse

1.6

9.5

216

1385

C07AA05

ATC

propranolol; systemic

1.4

9.4

421

3108

N06AA09

ATC

amitriptyline; systemic

1.7

9.4

178

1087

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.3

9.4

330

E930W

ICD-9 Finland

Antibiotics[MUUT MÄÄRITELLYT ANTIBIOOTIT]

100.4

9.4

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

17.6

9.4

M01AH02

ATC

rofecoxib; oral

1.6

9.4

235

1541

R07.3

ICD-10 Finland

Other chest pain

1.6

9.3

214

1373

ZXA10

NOMESCO Finland

Bilateral

1.5

9.3

362

2603

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

4.4

9.3

N30.0

ICD-10 Finland

Acute cystitis

1.5

9.3

375

2716

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

2.7

9.3

185

A28

ICPC

Limited function/disability NOS

1.5

9.3

343

2443

R52.9

ICD-10 Finland

Pain, unspecified

1.6

9.2

212

1361

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.7

9.2

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

9.1

328

K07

ICPC

Swollen ankles/oedema

2.0

9.1

496

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

9.1

704

5682

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

9.1

172

1051

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

9.1

428

XQ845

NOMESCO Finland

Dermatoscopy

3.0

9.1

137

C08CA13

ATC

lercanidipine; oral

1.5

9.1

268

1823

V03AE01

ATC

polystyrene sulfonate; oral

3.5

9.1

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

8.3

9.1

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

15.6

9.0

K02.1

ICD-10 Finland

Caries of dentine

1.3

9.0

1303

11454

SPAT1310

SPAT

Counselling related to known health issue

1.3

9.0

650

5191

N18.0

ICD-10 Finland

End-stage renal disease

4.1

9.0

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

8.9

357

L04AD02

ATC

tacrolimus; systemic

3.5

8.9

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

8.9

412

3059

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.7

8.9

172

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

24.1

8.9

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

8.9

370

2695

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

8.9

116

636

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.0

8.9

480

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

3.9

8.9

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.8

8.9

150

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4.7

8.8

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

8.8

392

2890

L30.4

ICD-10 Finland

Erythema intertrigo

3.5

8.8

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.2

8.8

108

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.2

8.8

103

S11

ICPC

Skin infection post-traumatic

3.2

8.8

103

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.3

8.7

270

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.6

8.7

197

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

8.7

203

1307

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.6

8.7

180

C09CA06

ATC

candesartan; oral

1.4

8.7

475

3628

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

50.2

8.7

XQ832

NOMESCO Finland

Other provocation test

50.2

8.7

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.3

8.7

R01AD01

ATC

beclometasone; nasal

1.5

8.7

292

2042

A07AA09

ATC

vancomycin; oral

3.1

8.6

109

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

8.6

296

2077

Z2446

NOMESCO Finland

Social worker

1.7

8.6

142

836

J02AC02

ATC

itraconazole; systemic

1.5

8.6

322

2299

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.3

8.6

279

M07.3

ICD-10 Finland

Other psoriatic arthropathies

3.6

8.6

WZA10

NOMESCO Finland

Extensive medical or dental certificate

3.1

8.6

115

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

8.5

305

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.0

8.5

126

A12AA04

ATC

calcium carbonate; oral

3.2

8.5

105

N03AB02

ATC

phenytoin; systemic

3.4

8.5

H60.1

ICD-10 Finland

Cellulitis of external ear

3.3

8.5

J04AB02

ATC

rifampicin; systemic

3.3

8.5

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.7

8.5

141

832

OAB50, ,

SPAT

1.7

8.5

163

1001

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

20.1

8.5

K07.60

ICD-10 Finland

Snapping jaw

1.8

8.5

118

661

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

8.4

151

909

M05BA04

ATC

alendronic acid; oral

1.7

8.4

171

1064

D06BX01

ATC

metronidazole; topical

1.6

8.4

203

1318

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

8.4

313

2230

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.2

8.4

326

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

2.8

8.4

143

XQ830

NOMESCO Finland

Exposure to foodstuff

90.4

8.4

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

8.4

269

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.7

8.4

155

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.4

8.4

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

4.7

8.3

L13

ICPC

Hip symptom/complaint

1.4

8.3

380

2812

M18.9

ICD-10 Finland

Arthrosis of first carpometacarpal joint, unspecified

3.3

8.3

J01XC01

ATC

fusidic acid; systemic

3.3

8.3

6929B

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]

+∞

8.3

R01AC01

ATC

cromoglicic acid; nasal

2.1

8.3

381

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

4.0

8.3

H25.8

ICD-10 Finland

Other senile cataract

1.6

8.3

198

1282

A07EC02

ATC

mesalazine; oral, rectal

1.9

8.3

107

584

N06AB04

ATC

citalopram; systemic

1.4

8.3

396

2953

M79.7

ICD-10 Finland

Fibromyalgia

2.1

8.3

368

K65.0

ICD-10 Finland

Acute peritonitis

3.6

8.3

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

8.3

507

WX882

NOMESCO Finland

High dependency care

2.2

8.3

290

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.0

8.2

123

B34.9

ICD-10 Finland

Viral infection, unspecified

2.1

8.2

336

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.3

8.2

284

EMB10

NOMESCO Finland

Tonsillectomy

1.8

8.2

127

734

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.6

8.2

168

L08

ICPC

Shoulder symptom/complaint

1.4

8.2

456

3490

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

8.2

630

5068

R06.2

ICD-10 Finland

Wheezing

1.9

8.2

516

B02.9

ICD-10 Finland

Zoster without complication

1.7

8.2

134

788

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

3.0

8.2

113

N06AB10

ATC

escitalopram; oral

1.4

8.2

432

3280

L04AC07

ATC

tocilizumab; parenteral

7.5

8.2

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

8.1

339

2468

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.0

8.1

447

ZXH09, ,

SPAT

2.4

8.1

223

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.8

8.1

126

730

E931A

ICD-9 Finland

Other anti-infectives[SULFONAMIDIT]

33.5

8.1

S01AD03

ATC

aciclovir; ophthalmic

2.2

8.1

319

R03BA08

ATC

ciclesonide; inhalant

1.6

8.1

166

1038

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

8.0

433

3296

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

8.9

8.0

B01AC04

ATC

clopidogrel; oral

1.5

8.0

283

1996

R05

ICD-10 Finland

Cough

1.4

8.0

442

3377

L21.0

ICD-10 Finland

Seborrhoea capitis

6.3

8.0

S70

ICPC

Herpes zoster

2.3

8.0

243

S91

ICPC

Psoriasis

3.9

8.0

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

8.0

422

L29.8

ICD-10 Finland

Other pruritus

3.5

8.0

UJK02

NOMESCO Finland

ERCP

2.4

8.0

231

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

8.0

443

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

8.0

185

1192

R06AX26

ATC

fexofenadine; oral

1.7

7.9

128

749

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

7.9

458

R31

ICD-10 Finland

Unspecified haematuria

1.6

7.9

181

1162

WQ000

NOMESCO Finland

Hyposensibilisation

4.4

7.9

H05AA02

ATC

teriparatide; parenteral

6.6

7.9

S01GX02

ATC

levocabastine; ophthalmic

1.8

7.9

113

639

K12.00

ICD-10 Finland

Recurrent oral aphthae

2.8

7.9

132

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.2

7.9

316

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

7.9

206

1365

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.6

7.8

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

7.8

135

805

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

7.8

104

574

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

7.8

257

1787

130

Kela drug reimbursment

Malignant tumour

1.6

7.8

160

999

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.8

7.8

108

604

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

4.1

7.8

R03BB07

ATC

umeclidinium bromide; inhalant

4.1

7.8

W19

ICD-10 Finland

Unspecified fall

1.6

7.8

195

1278

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

10.8

7.8

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.2

7.8

291

K50.8

ICD-10 Finland

Other Crohn disease

2.8

7.8

133

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

7.8

197

1296

QDB10, ,

SPAT

2.3

7.7

234

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

7.7

140

846

D11

ICPC

Diarrhoea

1.5

7.7

259

1808

L04AK01

ATC

leflunomide; oral

4.2

7.7

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.1

7.7

365

WIX00

NOMESCO Finland

Allergy cleanup guidance

45.1

7.7

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

7.7

224

1518

J01DC02

ATC

cefuroxime; systemic

1.8

7.7

110

621

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

7.7

210

1404

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

4.3

7.7

318

Kela drug reimbursment

Teriparatide

5.9

7.7

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.1

7.7

319

J01DA06

ATC

[U] cefuroxime

1.5

7.7

273

1929

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

7.7

306

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.8

7.6

134

TAB00

NOMESCO Finland

Lumbar puncture

1.9

7.6

464

J33.8

ICD-10 Finland

Other polyp of sinus

2.6

7.6

157

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.3

7.6

249

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

25.1

7.6

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

7.6

477

3720

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

7.6

261

1833

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

7.6

158

992

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

7.5

846

7144

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.8

7.5

124

L04AB06

ATC

golimumab; parenteral

3.8

7.5

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

7.5

495

M10

ICD-10 Finland

Gout

2.0

7.5

383

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

7.5

517

R00.2

ICD-10 Finland

Palpitations

1.6

7.5

166

1058

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.0

7.5

103

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.3

7.4

251

A01AB04

ATC

amphotericin B; local oral

1.9

7.4

461

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

3.9

7.4

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.1

7.4

330

D06BB03

ATC

aciclovir; topical

1.9

7.4

455

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

7.4

134

811

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.8

7.4

111

637

R21

ICPC

Throat symptom/complaint

1.3

7.4

477

3733

A06AC51

ATC

ispaghula, combinations; oral

1.9

7.4

484

IHZ05, ,

SPAT

1.8

7.3

104

586

C03DA01

ATC

spironolactone; oral

1.5

7.3

221

1509

M01CB01

ATC

sodium aurothiomalate; parenteral

2.9

7.3

115

R01AD11

ATC

triamcinolone; nasal

1.6

7.3

161

1024

WVA20

NOMESCO Finland

Medicine administration

2.2

7.3

279

6938X

ICD-9 Finland

Dermatitis due to substances taken internally, Due to other specified substances taken internally

+∞

7.3

69299

ICD-8 Finland

Other eczema and dermatitis, Due to other and unspecified cause

+∞

7.3

L27

ICD-10 Finland

Dermatitis due to substances taken internally

+∞

7.3

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.1

7.3

G40

ICD-10 Finland

Epilepsy

3.5

7.3

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

7.2

503

3978

R06.4

ICD-10 Finland

Hyperventilation

2.8

7.2

127

J01CF05

ATC

flucloxacillin; systemic

1.7

7.2

137

839

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

15.8

7.2

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

5.8

7.2

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.6

7.2

156

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

7.2

244

1708

V03AE02

ATC

sevelamer; oral

7.3

7.2

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

30.1

7.1

J01CA04

ATC

amoxicillin; systemic

1.3

7.1

1852

17277

R75

ICPC

Sinusitis acute/chronic

1.8

7.1

107

614

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

7.1

486

3833

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

7.1

331

2457

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

7.1

153

969

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

7.1

453

3538

WVA30, ,

SPAT

1.7

7.1

123

736

W10

ICD-10 Finland

Fall on and from stairs and steps

1.8

7.1

106

608

SPAT1262

SPAT

Handing over of treatment supplies

1.4

7.1

311

2285

J04BA02

ATC

dapsone; oral

6.0

7.1

JN6AD

NOMESCO Finland

CT of torso and neck

2.7

7.1

140

L03

ICPC

Low back symptom/complaint

1.3

7.1

612

4990

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.1

7.0

290

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.6

7.0

152

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

7.0

189

1260

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.5

7.0

176

ZXA05

NOMESCO Finland

Left side

1.3

7.0

449

3507

SPAT1240

SPAT

Therapeutic discussion

1.5

7.0

219

1508

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.2

7.0

245

H57.1

ICD-10 Finland

Ocular pain

1.9

7.0

464

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.3

7.0

226

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

7.0

129

785

N30.2

ICD-10 Finland

Other chronic cystitis

3.4

7.0

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.4

7.0

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.0

7.0

102

Z49.2

ICD-10 Finland

Other dialysis

4.4

7.0

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

7.0

136

840

49300

ICD-8 Finland

Asthma, bronchiale

2.5

6.9

177

N05AH04

ATC

quetiapine; oral

1.4

6.9

361

2731

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.7

6.9

136

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.2

6.9

240

L14

ICPC

Leg/thigh symptom/complaint

1.6

6.9

162

1047

S80.0

ICD-10 Finland

Contusion of knee

1.6

6.9

163

1055

WW300

NOMESCO Finland

Transfer of autologic stem cells

7.5

6.9

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

3.1

6.9

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

3.1

6.9

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

6.9

150

952

H65.3

ICD-10 Finland

Chronic mucoid otitis media

2.2

6.9

273

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

6.9

1585

14522

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

2.8

6.8

114

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

6.8

145

914

G44.2

ICD-10 Finland

Tension-type headache

1.4

6.8

275

1988

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

6.8

177

1170

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.4

6.8

WZC00, ,

SPAT

1.4

6.8

305

2247

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.0

6.8

383

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

6.8

137

853

J47

ICD-10 Finland

Bronchiectasis

2.6

6.8

149

L20

ICPC

Joint symptom/complaint NOS

1.9

6.8

419

M35.1

ICD-10 Finland

Other overlap syndromes

6.1

6.8

L51.19

ICD-10 Finland

Other bullous erythema multiforme

40.2

6.8

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

4.3

6.7

N77.1*A60.0

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in herpesviral [herpes simplex] infection

4.3

6.7

B05DA

ATC

Isotonic solutions

4.3

6.7

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.0

6.7

336

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.2

6.7

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

2.8

6.7

121

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.2

6.7

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

6.7

116

694

R4110, ,

SPAT

1.4

6.7

263

1894

C05AA08

ATC

fluocortolone; rectal, topical

1.5

6.7

235

1657

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.8

6.7

567

J94.8

ICD-10 Finland

Other specified pleural conditions

2.8

6.6

116

S28

ICPC

Limited function/disability (S)

3.7

6.6

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

2.9

6.6

105

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

4.0

6.6

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.7

6.6

107

628

7080A

ICD-9 Finland

Urticaria, Allergic urticaria

7.8

6.6

SPAT1216

SPAT

Assessment of functional ability

1.4

6.6

283

2070

M02AA10

ATC

ketoprofen; topical

1.4

6.6

291

2139

A01

ICPC

Pain general/multiple sites

1.5

6.6

205

1410

B86

ICD-10 Finland

Scabies

2.1

6.6

278

P25

ICPC

Phase of life problem adult

1.8

6.6

525

P03

ICPC

Feeling depressed

1.5

6.6

225

1578

I45.9

ICD-10 Finland

Conduction disorder, unspecified

3.5

6.6

R4180

NOMESCO Finland

Podiatric therapy

3.0

6.5

J01CF02

ATC

cloxacillin; systemic

2.4

6.5

176

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

3.8

6.5

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

6.5

126

776

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.8

6.5

563

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.4

6.5

170

R4110

NOMESCO Finland

Physiotherapy

1.3

6.5

537

4345

TQW99

NOMESCO Finland

Other minor procedure on skin

1.8

6.5

527

ULC02

NOMESCO Finland

Hysteroscopy

1.8

6.5

542

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.3

6.5

208

H60.8

ICD-10 Finland

Other otitis externa

2.1

6.5

300

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

6.5

317

2373

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.6

6.4

148

952

H53.4

ICD-10 Finland

Visual field defects

2.4

6.4

165

UJF92

NOMESCO Finland

Capsular endoscopy

2.3

6.4

196

WXQ10

NOMESCO Finland

Psoralen - Ultraviolet A therapy with systemic sensitivisation

70.0

6.4

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.1

6.4

274

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.3

6.4

190

R52.2

ICD-10 Finland

Other chronic pain

1.9

6.4

413

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.0

6.4

322

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.6

6.4

130

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

6.4

537

R01AD05

ATC

budesonide; nasal

1.6

6.4

137

867

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

6.4

559

4557

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

6.4

115

696

A08

ICPC

Swelling

1.7

6.4

107

635

ZX100

NOMESCO Finland

Oral

2.9

6.4

102

L29

ICD-10 Finland

Pruritus

2.9

6.4

102

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.1

6.4

R09

ICPC

Sinus symptom/complaint

1.5

6.3

174

1166

R06AX11

ATC

astemizole; oral

2.1

6.3

276

ZY010, ,

SPAT

2.6

6.3

131

128

Kela drug reimbursment

Cancers of female genital organs

2.4

6.3

173

D72.1

ICD-10 Finland

Eosinophilia

6.0

6.3

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.5

6.3

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.4

6.3

161

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.7

6.3

114

J35.0

ICD-10 Finland

Chronic tonsillitis

1.7

6.3

109

653

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.0

6.3

297

L29.0

ICD-10 Finland

Pruritus ani

3.9

6.3

R68.2

ICD-10 Finland

Dry mouth, unspecified

3.9

6.3

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

6.3

108

646

L12

ICPC

Hand/finger symptom/complaint

1.4

6.3

357

2737

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.3

6.3

186

6918C

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[DIATHESIS (CONSTITUTIO) ATOPICA]

+∞

6.3

69282

ICD-8 Finland

Other eczema and dermatitis, E microbis

+∞

6.3

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

6.2

420

3300

C09CA03

ATC

valsartan; oral

1.5

6.2

162

1072

J37.0

ICD-10 Finland

Chronic laryngitis

2.0

6.2

318

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.2

6.2

218

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.4

6.2

180

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.8

6.2

453

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.4

6.2

174

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.4

6.2

162

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.0

6.2

312

M05BA07

ATC

risedronic acid; oral

2.1

6.2

278

L43.8

ICD-10 Finland

Other lichen planus

2.6

6.2

138

J01AA04

ATC

lymecycline; systemic

1.4

6.2

253

1834

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.9

6.2

375

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.5

6.2

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.8

6.2

104

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.2

6.1

226

R05

ICPC

Cough

1.3

6.1

517

4190

R03BC01

ATC

cromoglicic acid; inhalant

2.6

6.1

127

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.2

6.1

220

H16.0

ICD-10 Finland

Corneal ulcer

1.7

6.1

560

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.0

6.1

328

1XC02, ,

NOMESCO Finland

3.8

6.1

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

4.1

6.1

J01DA08

ATC

[U] cefaclor

1.4

6.1

251

1823

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

12.5

6.1

120

Kela drug reimbursment

Hypogammaglobulinaemia

12.5

6.1

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

6.1

1481

13552

XCC00

NOMESCO Finland

Investigative irrigation of lacrimal passages

2.8

6.1

105

SPAT1097

SPAT

Recording of ECG

1.4

6.0

251

1825

R60.1

ICD-10 Finland

Generalized oedema

3.6

6.0

1CX01, ,

NOMESCO Finland

10.0

6.0

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

2.5

6.0

146

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768443) Skin Pathology biopsy report

280

628

4.91

117.71

1.4

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

30.40

103.07

1.0

1.1

0.07

0.02

u/ml

0.65

(3001604) Monocytes [#/volume] in Blood

1588

10415

2.55

100.20

11.8

6.3

0.58

0.57

e9/l

1.08

1473

8907

(42870588) Differential panel, method unspecified - Blood

1194

6904

2.45

99.25

11.6

6.4

—

(3006315) Basophils [#/volume] in Blood

1587

10435

2.53

99.09

11.8

6.3

0.04

e9/l

0.46

1470

8920

(3005322) IgE [Units/volume] in Serum or Plasma

388

1258

3.49

97.74

1.7

1.3

438.06

137.55

u/ml

3.69

364

1161

(3023368) Bacteria identified in Blood by Culture

994

5323

2.48

97.48

6.4

4.2

—

(3013115) Eosinophils [#/volume] in Blood

1614

10770

2.52

96.36

12.3

6.5

0.21

0.18

e9/l

4.66

1508

9373

(3019198) Lymphocytes [#/volume] in Blood

1606

10708

2.51

95.79

12.0

6.3

1.90

1.95

e9/l

0.21

1516

9410

(3013650) Neutrophils [#/volume] in Blood by Automated count

1688

11721

2.48

88.69

17.2

9.5

4.21

4.06

e9/l

1.97

1565

10130

(3019420) Tryptase [Mass/volume] in Serum or Plasma

11.23

83.70

1.3

1.6

6.30

10.17

ug/l

0.74

(3019069) Monocytes/Leukocytes in Blood

1454

9648

2.28

81.91

12.6

6.5

8.66

8.72

0.35

1387

9061

(3006504) Eosinophils/Leukocytes in Blood

1446

9634

2.26

79.78

12.6

6.5

3.08

2.76

4.25

1382

9040

(3022096) Basophils/Leukocytes in Blood

1442

9633

2.24

78.53

12.7

6.5

0.67

0.08

1377

9033

(3005719) IgG [Mass/volume] in Serum or Plasma

415

1587

2.95

78.13

4.4

2.8

10.27

10.63

g/l

0.77

387

1467

(3002030) Lymphocytes/Leukocytes in Blood

1471

9955

2.23

76.88

12.5

6.4

26.68

28.35

6.93

1420

9461

(3018010) Neutrophils/Leukocytes in Blood

1450

9759

2.22

76.80

12.1

6.3

58.05

57.01

2.56

1401

9334

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

208

540

4.12

71.70

2.8

1.8

1.15

1.19

g/l

0.79

201

514

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1352

9013

2.14

71.19

10.1

6.4

1.21

mmol/l

1.87

1266

8340

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1507

10484

2.17

70.89

10.6

6.4

10.63

11.38

umol/l

1.20

1444

9970

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

203

522

4.16

70.87

2.8

1.8

0.22

0.23

g/l

0.68

193

497

(3007853) Bacteria identified in Skin by Aerobe culture

506

2256

2.57

70.11

2.1

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

156

333

4.94

68.85

2.1

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

591

2876

2.40

67.46

1.6

1.4

681.58

506.10

titre

1.21

152

607

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1451

10060

2.12

67.35

11.6

7.0

1.21

mmol/l

1.00

1252

8706

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

651

3326

2.31

66.27

2.6

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

200

535

3.99

66.07

2.1

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

332

1235

2.96

65.03

2.5

1.9

1.14

1.34

g/l

0.97

305

1143

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

193

521

3.94

62.90

2.1

1.6

—

(3023420) DNA double strand Ab [Units/volume] in Serum

241

780

3.32

59.70

3.2

1.8

14.29

7.80

iu/ml

1.06

181

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

167

424

4.16

59.15

7.4

6.6

284.47

479.64

iu/ml

0.68

(3024561) Albumin [Mass/volume] in Serum or Plasma

1289

8829

1.99

58.50

8.4

5.0

34.96

35.88

g/l

6.68

1211

8297

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

480

2268

2.40

57.60

6.4

4.3

245.53

243.69

u/l

0.10

452

2152

(3032080) INR in Blood by Coagulation assay

1294

8916

1.98

57.26

14.8

14.0

1.19

1.23

inr

2.54

1104

7397

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

127

7.07

56.95

2.5

2.6

—

(3011412) CD3 cells [#/volume] in Blood

100

170

6.09

56.54

2.9

2.7

1188.26

1113.91

e6/l

0.34

147

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1915

15306

2.24

54.61

15.4

7.8

81.14

78.44

u/l

1.41

1849

14521

(3017181) Myelocytes/Leukocytes in Blood

402

1812

2.46

53.22

7.2

4.4

0.94

0.97

0.09

205

518

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

225

754

3.19

52.46

2.6

1.9

1.42

1.71

ug/l

0.24

199

663

(3002179) Metamyelocytes/Leukocytes in Blood

384

1721

2.47

51.35

7.0

4.1

0.75

0.71

0.14

191

491

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

336

1430

2.57

50.08

2.0

1.7

—

(3042936) Bacteria identified in Isolate by Culture

535

2795

2.18

49.77

2.6

2.0

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

600

3303

2.09

48.55

5.9

3.7

0.81

0.82

mmol/l

1.06

577

3115

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

964

6263

1.90

48.27

3.9

2.6

57.06

71.38

u/l

0.57

893

5792

(3036481) Cortisol [Moles/volume] in Serum or Plasma

416

1992

2.32

47.66

3.2

2.1

332.68

383.19

nmol/l

5.92

389

1841

(40760892) CBC W Ordered Manual Differential panel - Blood

769

4668

1.95

47.01

8.2

4.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

574

3176

2.06

45.43

3.2

2.5

2.32

2.35

g/l

0.57

535

2938

(3022948) Iron [Moles/volume] in Serum or Plasma

606

3421

2.03

45.37

3.2

2.5

12.38

13.39

umol/l

3.12

577

3195

(3021440) Promyelocytes/Leukocytes in Blood

373

1739

2.36

45.31

7.5

4.5

0.10

0.11

0.25

176

445

(3025159) Blasts/Leukocytes in Blood

376

1760

2.35

45.25

7.7

4.7

0.63

0.10

0.56

179

423

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

10.62

44.70

1.6

1.4

35.00

24.91

u/ml

—

(3004809) Band form neutrophils/Leukocytes in Blood

122

303

4.19

44.39

3.7

3.9

2.18

1.59

0.59

109

272

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

128

333

4.00

43.74

3.7

651.75

1980.96

u/ml

—

(3017732) Neutrophils [#/volume] in Blood

488

2578

2.12

43.50

4.3

3.0

5.25

4.52

e9/l

0.64

417

2255

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

155

463

3.51

43.33

1.8

1.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

196

677

3.06

43.22

1.4

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

473

2475

2.13

43.20

2.3

1.8

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

496

2644

2.10

43.14

9.0

5.8

1.07

1.05

mmol/l

0.63

464

2453

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

109

254

4.45

43.08

2.1

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

364

1714

2.32

43.07

11.2

7.3

9.53

9.33

mmol/l

0.22

342

1648

(3007164) IgA [Mass/volume] in Serum or Plasma

719

4374

1.92

42.96

2.1

1.5

2.33

g/l

0.00

511

2727

(3020630) Protein [Mass/volume] in Serum or Plasma

337

1541

2.38

42.63

4.6

2.9

65.59

66.40

g/l

1.05

312

1424

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

108

252

4.44

42.61

2.0

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

305

1350

2.44

41.42

5.5

3.9

5.10

5.16

kpa

0.71

290

1308

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

135

380

3.70

41.24

1.8

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

527

2920

2.03

41.05

3.3

2.5

21.59

23.02

1.62

497

2725

(3009343) pH of Capillary blood

298

1313

2.45

40.86

5.5

3.9

7.42

0.10

254

1098

(3031040) Bacteria [#/volume] in Urine by Automated count

1697

13564

1.85

40.16

6.5

4.6

62.22

1899.25

e6/l

3.55

192

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

211

4.65

39.85

2.1

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

446

2354

2.10

39.49

2.4

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

182

635

3.02

39.38

3.1

2.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1055

7374

1.77

39.24

4.9

3.6

42.20

58.95

ng/l

0.69

777

4924

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

191

4.80

38.92

2.1

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1526

11883

1.78

38.58

7.7

4.9

6.60

6.62

mmol/l

0.14

1472

11166

(3018418) pH of Serum or Plasma

897

6018

1.78

38.14

6.3

4.1

7.40

0.85

682

4314

(3000494) Fungus identified in Specimen by Culture

432

2287

2.08

37.81

1.9

1.4

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1824

15032

1.89

37.68

7.9

4.2

14.52

11.50

mm/h

12.52

1733

14052

(3035350) Ketones [Presence] in Urine by Test strip

1442

11096

1.75

37.49

5.4

3.8

0.00

3.46

estimate

1.58

336

2392

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

898

6055

1.77

37.33

2.8

2.2

151.92

218.19

u/l

2.23

854

5741

(3004588) Protein electrophoresis panel - Serum or Plasma

273

1207

2.42

37.00

3.8

2.7

—

(3023520) Reticulocytes [#/volume] in Blood

351

1732

2.20

36.76

3.7

2.8

70.04

69.83

e9/l

0.04

274

1264

(3021601) Nitrite [Presence] in Urine by Test strip

1425

10968

1.74

36.62

5.4

3.8

0.00

estimate

0.80

334

2341

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

129

5.56

36.37

3.3

3.0

240.48

205.32

e6/l

0.46

108

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

113

308

3.80

36.15

1.8

1.5

—

(21494814) CD8 cells/Lymphocytes in Specimen

7.92

35.79

2.3

1.8

33.37

28.86

0.97

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

838

5593

1.77

35.72

3.7

3.2

1434.49

1284.28

ng/l

0.43

720

4774

(3015171) Extractable nuclear Ab [Units/volume] in Serum

199

768

2.73

35.69

1.4

1.2

2.88

1.02

u/ml

0.47

(3027945) Reticulocytes/Erythrocytes in Blood

423

2267

2.05

35.64

3.7

3.0

1.81

1.79

0.14

382

2026

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

262

1156

2.42

35.62

5.4

3.8

1.70

1.71

mmol/l

0.02

193

848

(3009261) Glucose [Presence] in Urine by Test strip

1440

11167

1.72

35.50

5.5

3.8

0.01

0.14

estimate

0.50

322

2262

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

135

419

3.35

35.49

1.5

1.2

15.81

4.04

u/ml

0.43

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1262

9479

1.70

34.68

3.1

2.5

75.39

76.64

nmol/l

0.85

1171

8647

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

153

4.96

33.82

1.7

1.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

707

4551

1.78

33.76

2.0

1.8

1.16

1.25

mg/l

0.37

561

3488

(3035715) Granulocytes [#/volume] in Blood

118

347

3.52

33.74

3.8

3.2

4.51

3.94

e9/l

1.52

118

347

(3015736) pH of Urine

1190

8842

1.69

33.69

4.6

3.4

6.25

0.03

642

4949

(3026493) Urate [Moles/volume] in Serum or Plasma

764

5032

1.76

33.69

3.9

2.7

336.69

335.25

umol/l

0.14

683

4467

(3017143) Hepatitis C virus Ab [Presence] in Serum

472

2684

1.94

33.40

2.0

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

174

660

2.76

32.22

1.8

1.5

2.47

0.06

iu/ml

0.61

117

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

368

1950

2.05

31.71

3.2

2.4

0.21

g/l

0.39

336

1825

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

152

541

2.93

31.67

1.6

1.2

18.42

7.25

u/ml

0.84

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

151

540

2.92

31.19

1.5

1.2

12.22

2.72

u/ml

0.58

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

125

401

3.23

31.14

1.8

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

509

3032

1.86

31.00

2.4

2.3

29.37

29.39

0.03

497

2958

(3000850) Epithelial cells [#/volume] in Urine

687

4497

1.74

30.37

3.9

2.6

5.85

6.43

e6/l

0.56

644

4081

(3030467) Casts [#/volume] in Urine by Automated count

823

5665

1.69

30.22

4.4

3.2

0.44

0.43

e6/l

0.05

657

4091

(3017354) Segmented neutrophils/Leukocytes in Blood

191

4.24

29.78

3.5

3.4

59.60

57.43

0.35

169

(3021879) Hepatitis B virus core Ab [Presence] in Serum

337

1768

2.05

29.73

1.6

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

154

573

2.80

29.55

1.6

1.2

54.55

47.25

u/ml

0.11

(3037756) Immunofixation for Serum or Plasma

117

373

3.25

29.45

2.2

1.7

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

37.56

29.32

1.1

0.03

0.06

u/ml

—

(3029937) Albumin [Presence] in Urine by Test strip

867

6092

1.66

29.19

5.7

3.8

0.00

estimate

1.54

310

2197

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

129

4.99

29.13

3.2

2.9

608.53

459.49

e6/l

1.23

104

(3035933) Granulocytes/Leukocytes in Blood

132

455

3.01

29.10

4.0

3.0

59.97

57.90

0.86

132

455

(44806118) Parainfluenza type 4 nucleic acid detection

277

3.61

28.99

1.9

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

277

3.61

28.99

1.9

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

277

3.61

28.99

1.9

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

277

3.61

28.99

1.9

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

803

5547

1.67

28.78

3.1

2.3

3.01

2.77

mg/l

2.18

699

4813

(3008757) Leukocyte morphology finding [Identifier] in Blood

196

4.08

27.95

4.4

4.8

—

(3026008) Bacteria identified in Urine by Culture

889

6368

1.63

27.26

4.2

3.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

114

375

3.14

27.24

5.6

4.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

242

3.69

27.04

1.3

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

907

6552

1.62

26.74

4.7

3.3

31.63

75.86

e6/l

2.13

745

4925

(3012494) Peanut IgE Ab [Units/volume] in Serum

8.61

26.66

1.1

1.66

2.23

u/ml

0.10

(3034860) Kappa light chains.free [Mass/volume] in Serum

152

596

2.66

26.34

5.2

4.0

74.17

61.88

mg/l

0.18

124

524

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

596

3882

1.71

26.21

1.4

1.3

32.56

31.65

iu/ml

0.06

190

1172

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

152

598

2.65

26.16

5.2

4.0

39.43

77.87

mg/l

0.76

125

525

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

602

3937

1.71

26.06

2.0

1.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

147

572

2.67

25.86

1.4

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

463

2818

1.80

25.79

3.6

2.5

124.35

121.67

ug/g

0.08

367

2253

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

125

448

2.89

25.70

1.5

1.6

—

(3018095) Leukocytes [#/volume] in Urine

1027

7702

1.58

25.52

5.4

3.8

95.81

91.13

e6/l

0.06

778

5230

(3026782) Osmolality of Urine

592

3886

1.69

25.15

4.2

2.9

499.76

532.01

mosm/kgh2o

3.18

535

3403

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

163

4.20

25.08

1.8

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

163

4.20

25.08

1.8

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

163

4.20

25.08

1.8

1.5

—

(3021589) Normoblasts [#/volume] in Blood

1188

9242

1.56

24.95

21.2

11.0

0.00

e9/l

0.31

1030

7518

(36304419) Bacteria [Presence] in Urine

772

5433

1.62

24.93

4.4

3.1

0.00

estimate

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

136

520

2.71

24.76

5.2

3.9

16.61

3.99

ratio

0.79

305

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

134

511

2.72

24.52

2.4

2.2

12.81

11.52

mg/l

0.61

125

470

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1087

8314

1.56

24.44

5.4

3.7

0.37

0.09

estimate

0.36

283

1917

(3019309) Folate [Moles/volume] in Red Blood Cells

507

3214

1.73

24.37

1.9

1.7

1246.11

1172.31

nmol/l

0.95

386

2468

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

123

451

2.82

24.25

1.7

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

322

3.16

24.12

2.1

1.3

9.68

11.32

u/ml

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1304

10413

1.55

23.99

4.1

3.1

147.22

107.31

ug/l

2.25

1226

9776

(3044640) Blood type and Crossmatch panel - Blood

923

6823

1.57

23.98

3.3

2.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

174

761

2.39

23.93

6.6

4.2

24.70

24.79

mmol/l

0.15

162

711

(3027135) IgG subclass 1 [Mass/volume] in Serum

187

3.88

23.87

1.5

6.26

6.93

g/l

0.41

137

(3024139) IgG subclass 3 [Mass/volume] in Serum

187

3.88

23.87

1.5

0.39

0.40

g/l

0.07

139

(3028192) IgG subclass 2 [Mass/volume] in Serum

187

3.88

23.87

1.5

2.40

2.95

g/l

1.53

139

(3024980) IgG subclass 4 [Mass/volume] in Serum

319

3.16

23.85

1.6

1.7

0.58

0.78

g/l

0.89

251

(3003396) Base excess in Arterial blood by calculation

380

2231

1.84

23.67

9.5

7.9

1.28

0.95

mmol/l

0.83

307

1827

(3019977) pH of Arterial blood

381

2240

1.83

23.62

9.7

7.9

7.42

1.23

232

1198

(4062490) Immunoglobulin typing, IgG

184

3.89

23.61

1.6

1.5

—

(3022313) Gas panel - Capillary blood

200

935

2.24

23.55

6.6

4.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

145

4.29

23.54

2.1

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

318

3.14

23.33

1.4

1.2

203.33

317.27

titre

0.30

(3021960) Folate [Moles/volume] in Serum or Plasma

794

5704

1.59

23.15

1.9

1.7

19.56

20.21

nmol/l

0.58

698

4853

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

549

3602

1.68

23.10

1.4

1.3

16.21

11.39

u/ml

0.26

213

1407

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

5.67

23.06

2.4

2.2

2864.86

43658.36

u/ml

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

212

1025

2.17

22.96

1.6

1.5

—

(3019060) Gas panel - Arterial blood

222

1098

2.13

22.69

5.2

4.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

180

819

2.29

22.60

1.5

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

944

7083

1.55

22.58

4.8

3.4

2.33

2.35

mmol/l

5.65

877

6475

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1231

9785

1.53

22.55

3.6

2.8

—

estimate

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

723

5118

1.59

22.27

3.2

2.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

187

870

2.25

22.26

2.0

1.8

1.67

1.50

g/l

1.33

164

765

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

120

455

2.72

22.21

1.7

1.4

—

21.82

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

376

2247

1.80

21.98

9.8

7.9

5.02

5.11

kpa

1.02

358

2152

(3027801) Oxygen [Partial pressure] in Arterial blood

376

2248

1.80

21.95

9.8

7.9

12.17

12.46

kpa

0.50

356

2152

(3033658) Prothrombin time (PT) actual/Normal

727

5184

1.58

21.57

5.7

4.2

91.39

90.57

0.39

704

5080

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

720

5126

1.58

21.50

1.4

1.3

1.12

1.59

u/ml

0.88

195

1384

(3016502) Oxygen saturation in Arterial blood

340

1986

1.83

21.40

9.9

8.3

95.36

95.70

0.41

324

1918

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

130

523

2.57

21.38

2.1

1.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

162

3.90

21.10

1.4

1.2

73.63

66.91

u/ml

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

226

1161

2.04

20.84

8.0

6.4

24.69

24.49

mmol/l

0.33

217

1103

(46235355) HIV 1 and 2 tests - Meaningful Use set

666

4687

1.58

20.77

2.3

2.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

209

3.47

20.32

1.7

1.5

62.65

60.75

0.15

131

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

110

418

2.71

20.28

1.8

1.5

166.21

148.84

au/ml

0.67

132

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2192

20171

1.99

20.25

31.1

14.6

21.89

23.34

mg/l

1.63

1992

16437

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

162

739

2.28

20.20

2.5

1.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

178

845

2.20

20.15

2.5

2.0

38.39

39.65

u/l

0.34

161

760

(4035726) Immunohistochemistry procedure

300

1717

1.85

20.10

1.6

1.4

—

(3028433) Virus identified in Specimen by Culture

5.90

19.64

1.2

1.4

—

(3012544) pH of Venous blood

340

2038

1.78

19.53

5.1

4.1

7.38

0.06

207

1164

(3021447) Carbon dioxide [Partial pressure] in Venous blood

339

2035

1.78

19.37

5.4

4.1

5.73

5.80

kpa

0.65

329

1976

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1112

8829

1.48

19.35

2.4

2.1

96.31

96.58

pmol/l

0.06

671

4657

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

117

471

2.56

19.23

1.6

1.3

315.46

254.91

u/ml

0.97

292

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

5.93

19.17

1.1

1.2

0.31

0.29

g/l

0.70

(3011897) Casein IgE Ab [Units/volume] in Serum

16.87

19.16

1.4

1.0

21.66

0.02

u/ml

0.68

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

150

678

2.29

19.11

2.2

1.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

5.71

18.99

1.5

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

593

4137

1.58

18.93

1.8

1.7

73631281.78

27087363.12

pmol/l

0.66

493

3474

(3002173) Hemoglobin [Mass/volume] in Arterial blood

315

1863

1.80

18.90

11.0

8.7

119.16

121.37

g/l

1.15

308

1818

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

620

4388

1.56

18.51

1.7

—

(3002032) Base excess in Venous blood by calculation

327

1973

1.76

18.30

5.5

4.2

1.74

1.81

mmol/l

0.14

291

1680

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

329

1990

1.76

18.25

4.6

3.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

155

726

2.21

18.13

4.2

2.6

3.51

3.65

g/l

0.67

145

668

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

155

727

2.21

18.07

4.2

2.6

4.26

4.23

g/l

0.19

145

668

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

155

727

2.21

18.07

4.2

2.6

7.39

7.43

g/l

0.10

145

668

(40758558) Short blood count panel - Blood

826

6243

1.49

18.02

11.5

6.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

258

3.05

17.89

1.5

1.1

35.63

10.01

u/ml

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

158

3.67

17.87

1.6

1.2

3.22

0.70

u/ml

0.77

(1616796) Gas panel - Central venous blood

108

434

2.56

17.83

5.0

3.6

—

(3019225) pH of Specimen

308

1842

1.77

17.75

6.6

4.0

7.36

7.35

0.47

232

1327

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

133

598

2.30

17.16

1.4

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

6.91

16.98

2.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

145

682

2.20

16.79

3.8

2.7

2.87

2.99

g/l

0.73

135

623

(3045424) Erythrocytes [Presence] in Urine

186

968

2.00

16.49

2.7

2.1

0.43

0.80

estimate

0.17

318

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

138

641

2.22

16.48

2.7

3.3

3.77

3.56

g/l

0.88

130

614

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

136

628

2.24

16.48

3.5

2.8

0.92

1.24

g/l

0.32

110

549

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

130

3.83

16.38

2.1

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

265

1555

1.79

16.24

5.2

3.8

98.54

82.59

ng/l

1.59

228

1357

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

359

2292

1.67

16.24

4.2

3.1

8.15

7.52

umol/l

0.21

314

2011

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

100

4.26

16.23

1.4

1.2

—

(3025941) Bacteria identified in Stool by Culture

209

1142

1.91

16.07

1.4

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

114

4.00

16.03

2.2

1.5

—

(3000991) Gas panel - Venous blood

294

1789

1.73

15.87

11.6

9.2

—

(3045414) Leukocytes [Presence] in Urine

314

1946

1.71

15.86

2.5

2.1

0.00

0.02

estimate

1.06

418

(3014111) Lactate [Moles/volume] in Serum or Plasma

299

1829

1.72

15.84

9.4

8.0

1.48

1.32

mmol/l

1.21

291

1791

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

120

3.89

15.75

2.7

35.44

41.15

1.05

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

217

1210

1.87

15.67

2.0

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

219

3.07

15.63

1.6

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

115

506

2.34

15.62

1.7

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

895

7018

1.44

15.55

5.3

3.3

32.17

31.15

u/l

0.29

841

6647

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

19.34

15.54

1.1

0.22

0.02

u/ml

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

308

2.72

15.51

2.1

1.8

—

(3037121) Protein [Mass/volume] in Urine

146

714

2.11

15.32

4.2

3.4

1337.66

300.03

mg/l

0.53

309

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

162

3.39

15.07

1.3

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.71

14.94

2.1

1.8

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.71

14.94

2.1

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.71

14.94

2.1

1.8

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

242

1416

1.79

14.94

2.5

2.4

25.07

19.47

au/ml

0.39

156

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

4.09

14.72

2.0

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

4.09

14.72

2.0

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

4.09

14.72

2.0

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

4.09

14.72

2.0

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

117

3.81

14.68

2.2

1.5

—

(3042631) Mycobacterium sp identified in Specimen

244

2.88

14.63

3.6

2.8

—

(3012501) Base excess in Blood by calculation

402

2.45

14.57

5.2

4.0

2.22

2.52

mmol/l

0.58

267

(3000060) B lymphocytes [#/volume] in Blood

4.97

14.52

2.0

2.9

1.49

0.16

e9/l

0.51

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

5.44

14.48

1.2

111.43

104.24

0.73

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1807

16177

1.47

14.46

5.6

4.4

14.83

14.70

pmol/l

1.35

1671

14917

(3014599) Egg white IgE Ab [Units/volume] in Serum

123

3.71

14.45

1.2

1.0

9.86

0.46

u/ml

2.20

(3022145) Colonoscopy Study observation

342

2235

1.62

13.98

1.5

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

290

2.67

13.97

1.3

1.4

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

253

1536

1.72

13.71

3.7

2.7

65.26

68.42

ml/min/173m2

0.64

122

632

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

222

1299

1.78

13.69

1.3

29.45

45.35

au/ml

0.71

(3024354) Oxygen [Partial pressure] in Venous blood

276

1721

1.68

13.55

5.5

3.6

4.62

4.56

kpa

0.18

267

1671

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

102

454

2.30

13.52

1.6

1.2

41.33

48.31

u/ml

—

(3023419) Bacteria identified in Sputum by Culture

244

2.80

13.48

5.3

2.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

406

2.37

13.35

2.1

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

776

6058

1.41

13.32

4.6

3.2

1.06

0.20

estimate

0.44

269

1856

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

113

532

2.18

13.09

3.6

2.8

0.00

0.02

g/l

1.14

485

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

488

3501

1.49

13.07

3.6

2.8

1.02

1.31

e6/l

0.69

294

1794

(3019550) Sodium [Moles/volume] in Serum or Plasma

2160

20211

1.68

13.07

31.7

17.1

139.37

139.68

mmol/l

7.33

2130

19787

(3023103) Potassium [Moles/volume] in Serum or Plasma

2163

20252

1.68

12.98

32.0

17.2

3.96

mmol/l

0.42

2134

19793

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

126

624

2.08

12.82

4.2

2.8

10.48

10.23

g/l

0.18

114

562

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1576

13887

1.39

12.77

5.0

3.3

54.11

43.77

u/l

3.67

1498

13143

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1551

13635

1.39

12.72

3.7

3.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

366

2.40

12.63

1.2

1.1

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

237

1448

1.71

12.53

1.6

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

5.04

12.42

4.1

2.9

1.27

2.63

ratio

2.26

(3019150) Specific gravity of Urine by Refractometry

645

4923

1.42

12.40

5.3

3.9

1.02

1.33

kg/l

0.50

425

3249

(3010375) cycloSPORINE [Mass/volume] in Blood

4.04

12.38

28.0

31.2

106.31

124.25

ug/l

0.82

(3006922) Hepatitis E virus Ab [Presence] in Serum

157

3.17

12.36

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

134

689

2.00

12.31

2.4

188.35

434.99

ug/l

2.24

123

650

(3003181) Sodium [Moles/volume] in Urine

358

2.40

12.31

1.3

1.4

65.55

65.40

mmol/l

0.01

294

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

11.67

12.30

1.2

1.0

2.39

0.44

u/ml

0.55

(3020874) Milk IgE Ab [Units/volume] in Serum

118

3.52

12.24

1.3

1.0

15.90

0.97

u/ml

1.02

(3030981) Hyaline casts [#/volume] in Urine by Automated count

248

1544

1.68

12.22

3.1

2.4

0.67

0.55

e6/l

0.20

234

1480

(3039162) Centromere protein B Ab [Units/volume] in Serum

240

2.71

12.21

1.7

1.3

0.66

84.68

u/ml

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

252

1581

1.66

12.05

6.8

3.6

1.22

1.23

mmol/l

0.93

221

1357

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

364

2.36

11.87

1.1

—

(40768797) Stomach Pathology biopsy report

390

2722

1.52

11.83

1.3

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

191

1116

1.77

11.82

13.6

10.3

15.76

15.98

0.54

182

1068

(3047181) Lactate [Moles/volume] in Blood

115

570

2.07

11.69

6.6

5.5

1.21

1.28

mmol/l

0.47

102

495

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

318

2.44

11.61

1.4

28.59

25.10

u/l

0.36

262

(3003129) Base excess in Capillary blood by calculation

209

2.77

11.37

2.2

2.1

-0.43

0.67

mmol/l

1.29

203

(21494890) Protein electrophoresis panel - 24 hour Urine

182

2.90

11.30

2.6

2.2

—

(3034770) Mitochondria Ab [Titer] in Serum

119

606

2.01

11.25

1.3

—

1019.41

—

(40761536) Microorganisms panel - Urine sediment

267

1730

1.61

11.22

6.6

3.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

101

3.60

11.18

1.5

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

102

3.57

11.03

1.5

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

107

3.50

10.99

1.1

1.2

1.57

16.00

u/ml

—

(3000475) Leukocytes [#/volume] in Synovial fluid

100

482

2.12

10.96

2.0

1.6

22712.24

12673.11

e6/l

0.71

344

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

511

3814

1.43

10.94

4.9

3.7

220.40

456.81

ng/l

2.06

364

2857

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

111

557

2.04

10.94

1.3

—

(40768804) Tissue Pathology biopsy report

975

8091

1.35

10.91

2.3

2.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

405

2.22

10.83

1.1

10.08

4.76

u/ml

1.46

215

(3045142) Bone marrow Pathology biopsy report

222

2.65

10.67

1.5

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

116

598

1.99

10.61

3.5

3.6

0.35

0.36

iu/ml

0.16

314

(3007566) Smooth muscle Ab [Titer] in Serum

117

605

1.98

10.61

1.3

79.00

91.94

titre

—

(3017704) Immunofixation for Urine

100

3.54

10.60

1.4

1.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

475

2.11

10.60

1.1

2.06

2.00

u/ml

0.03

249

(3035637) Corticotropin [Mass/volume] in Plasma

265

2.49

10.53

1.6

1.5

27.34

29.05

ng/l

0.07

265

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

136

3.13

10.45

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.83

10.21

3.5

4.8

1.52

1.10

0.46

(3009508) Creatinine [Moles/volume] in Urine

836

6841

1.34

10.05

4.0

3.5

7.13

7.61

mmol/l

2.49

699

5853

(3008898) HLA-B27 [Presence]

140

783

1.84

10.03

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

102

515

2.02

9.91

3.6

2.8

0.00

g/l

-0.00

456

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

388

2.18

9.86

4.1

3.2

8.71

8.16

pmol/l

0.24

388

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

198

1232

1.66

9.76

12.9

10.4

0.70

0.65

1.05

192

1226

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

126

688

1.88

9.75

2.7

3.1

96.28

92.83

1.08

118

669

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

120

646

1.90

9.69

5.6

1.58

1.44

mg/l

0.93

112

599

(3007930) Methemoglobin/Hemoglobin.total in Blood

138

780

1.82

9.57

7.0

4.8

0.96

0.89

0.71

132

729

(36660697) Celiac disease serology panel - Serum

262

1753

1.56

9.57

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

322

2.27

9.53

1.3

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

746

6042

1.34

9.49

3.6

2.9

0.00

0.03

—

132

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

520

3983

1.39

9.44

4.1

2.9

2.44

2.45

mmol/l

0.30

481

3575

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

261

2.41

9.41

2.5

18.16

36.16

iu/ml

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

125

689

1.86

9.40

1.6

1.5

11.86

9.43

u/l

1.12

105

546

(3004119) Hemoglobin [Mass/volume] in Venous blood

195

1221

1.65

9.39

4.2

3.3

125.21

129.44

g/l

1.76

188

1188

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2030

19004

1.44

9.32

25.9

14.2

82.75

83.65

ml/min/173m2

0.99

1923

17450

(3000012) Reticulocyte production index

281

2.35

9.30

2.5

2.0

0.97

0.93

0.18

184

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

212

1359

1.61

9.29

3.1

3.4

4.51

4.55

pmol/l

0.22

191

1218

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

398

2.12

9.27

2.0

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

233

2.48

9.22

2.8

2.4

1.24

1.20

g/24h

0.04

132

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

146

850

1.76

9.18

6.8

4.6

1.76

1.58

0.55

139

797

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

202

1284

1.63

9.16

12.6

10.1

1.33

1.29

0.28

196

1275

(3012516) Albumin [Mass/volume] in Urine

754

6142

1.33

9.16

4.1

3.5

55.24

45.03

mg/l

0.58

475

3888

(3010726) Horse dander IgE Ab [Units/volume] in Serum

380

2.14

9.15

1.1

4.40

0.82

u/ml

1.30

179

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

247

2.42

9.07

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

116

3.14

9.07

1.2

1.0

1.12

0.24

u/ml

0.88

(3003329) Lymphocytes/Leukocytes in Synovial fluid

154

2.82

9.02

1.8

1.4

30.36

34.01

0.25

(3014133) Dog dander IgE Ab [Units/volume] in Serum

330

2.22

9.00

1.1

8.18

1.75

u/ml

2.03

150

(3008401) Mugwort IgE Ab [Units/volume] in Serum

396

2.11

9.00

1.1

2.31

0.99

u/ml

0.90

163

(3020682) Albumin/Creatinine [Ratio] in Urine

763

6241

1.33

8.97

4.9

4.2

9.99

7.83

mg/mmol

0.64

472

3867

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

249

2.40

8.92

1.5

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

112

607

1.89

8.89

4.6

3.7

1.35

1.38

mmol/l

0.12

107

598

(3039000) Anion gap in Blood by calculation

385

2.12

8.86

7.6

6.4

11.24

11.28

mmol/l

0.03

344

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

313

2.24

8.85

1.1

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

250

2.39

8.85

1.5

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

4.90

8.83

1.5

1.4

29.25

21.80

0.37

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

434

3258

1.41

8.81

3.8

3.0

3.88

2.70

e6/l

1.18

229

1548

(3018572) Chloride [Moles/volume] in Blood

386

2.11

8.81

7.7

6.4

104.42

105.27

mmol/l

0.80

345

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

104

552

1.92

8.79

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

130

742

1.80

8.75

1.7

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

252

2.38

8.70

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

415

2.06

8.69

2.8

3.2

28.16

34.74

umol/l

2.65

384

(3011841) English Walnut IgE Ab [Units/volume] in Serum

14.07

8.68

1.0

0.17

0.01

u/ml

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

130

2.95

8.66

1.4

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

130

746

1.79

8.60

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

103

553

1.90

8.43

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.44

8.22

6.2

4.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

235

2.37

8.12

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

483

1.94

8.06

3.8

2.9

0.00

g/l

-0.00

456

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2220

21265

1.58

8.03

35.5

18.7

80.15

74.86

umol/l

5.96

2205

21008

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

283

1996

1.47

8.03

3.1

2.3

36.56

62.00

u/l

0.52

242

1685

(3023430) Cat dander IgE Ab [Units/volume] in Serum

308

2.18

7.94

1.0

1.1

8.06

4.12

u/ml

0.74

120

(42529406) Shigella sp [Presence] in Stool by Culture

102

560

1.86

7.81

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

105

582

1.84

7.80

1.4

271.21

284.88

ug/g

0.25

324

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2007

18882

1.38

7.79

6.9

5.3

1.87

1.90

mu/l

0.40

1881

17598

(3011436) Histone Ab [Units/volume] in Serum

6.97

7.76

1.3

1.0

—

u/ml

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.55

7.69

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.55

7.69

1.6

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

299

2.17

7.69

1.1

—

1.26

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

300

2.16

7.63

5.8

5.6

368.74

365.52

umol/l

0.06

268

(3042733) HLA Ab [Presence] in Serum

3.61

7.57

5.5

4.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

243

2.29

7.56

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

244

2.28

7.49

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

244

2.28

7.49

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

146

901

1.66

7.47

2.2

1.7

0.35

0.31

mg/l

0.29

403

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

392

2.00

7.39

4.3

3.5

104.70

1037.48

u/ml

0.82

366

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

184

2.47

7.34

3.8

2.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

318

2332

1.42

7.31

5.0

4.7

32.00

32.39

0.24

232

1573

(3044290) Cell count panel - Cerebral spinal fluid

451

1.92

7.25

1.7

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

225

1547

1.50

7.24

2.3

5.48

7.46

ug/l

1.41

193

1368

(40768446) Kidney Pathology biopsy report

3.56

7.14

2.2

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

176

2.47

7.01

1.2

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1961

18475

1.33

6.81

7.1

5.9

39.15

38.82

mmol/mol

0.84

1832

17364

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

209

1434

1.50

6.80

3.9

2.8

173.39

197.28

ng/l

0.40

189

1306

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

229

1606

1.47

6.68

1.3

1.2

117.82

149.79

u/ml

0.50

588

(3036489) Thrombin time

133

827

1.64

6.64

2.5

2.7

20.52

21.15

0.94

117

732

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

151

2.54

6.61

1.3

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2200

21145

1.48

6.57

21.6

11.3

26.25

25.52

u/l

1.16

2161

20570

(3024471) HLA-A [Type]

3.46

6.56

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

104

608

1.74

6.52

1.2

1.1

3.95

4.15

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

272

1981

1.42

6.49

5.0

4.3

16.13

18.89

ug/l

0.16

221

1610

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

202

2.30

6.46

1.4

—

(21494434) Karyotype in Bone marrow

171

2.42

6.45

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

165

2.45

6.44

1.4

1.3

251694.76

102893.31

e6/l

0.40

109

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

209

2.27

6.41

1.6

1.4

—

(44813793) Dust mix specific IgE antibody measurement

119

2.71

6.34

1.1

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

150

2.49

6.19

1.3

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

5.34

6.15

1.4

1.1

81.53

92.50

0.51

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

331

2518

1.36

6.09

1.9

1.7

1.48

1.45

0.26

289

2214

(3016018) Differential panel - Cerebral spinal fluid

247

2.13

6.06

1.7

1.6

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

8.61

6.05

2.3

6.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

189

2.30

6.04

1.3

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

111

2.72

6.02

1.4

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

111

2.72

6.02

1.4

1.6

—

(3033099) Centromere Ab [Titer] in Serum

5.55

5.99

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

548

1.74

5.98

1.1

2.53

5.07

eliau/ml

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

129

2.58

5.96

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

381

1.89

5.92

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

381

1.89

5.92

1.4

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

4.02

5.89

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.54

5.88

1.6

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

298

2.00

5.86

1.0

0.89

0.05

u/ml

0.92

(3034891) Synovial lining cells/cells in Synovial fluid

2.96

5.84

1.6

1.3

1.43

2.31

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

493

1.77

5.81

1.7

1.6

2728.51

1256.21

e6/l

0.23

382

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.88

5.78

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

168

2.34

5.75

1.1

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

488

1.77

5.72

1.6

32.31

24.82

e6/l

0.18

357

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

175

2.31

5.70

1.4

1.3

80.50

76.67

—

(3008295) Osmolality of Serum or Plasma

228

2.13

5.62

1.7

1.4

275.82

279.74

mosm/kgh2o

0.62

172

(3047189) Immunofixation for 24 hour Urine

2.82

5.57

3.1

1.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

8.49

5.55

9.7

6.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

287

2167

1.37

5.53

10.6

6.5

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

10.04

5.53

1.0

0.06

0.03

u/ml

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

3.07

5.49

4.4

2.7

19.76

16.72

ug/l

0.40

(4034850) Laboratory test

601

1.68

5.47

12.3

10.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

3.03

5.37

1.1

29.71

257.28

ng/l

—

(3014271) Vancomycin [Susceptibility]

2.88

5.35

3.7

2.8

—

(3052851) Hemolysis interference index of Serum or Plasma

552

1.69

5.32

3.2

3.3

1.62

2.21

index

0.59

279

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

9.12

5.28

1.8

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

102

2.67

5.24

1.3

1.6

—

1565521.43

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

5.93

5.22

2.8

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.77

5.20

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

356

1.85

5.13

2.2

1.9

4.92

5.09

mmol/24h

0.16

314

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

108

683

1.61

5.11

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

513

1.70

5.09

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

2.86

5.08

3.4

4.3

8.12

9.22

mg/l

0.47

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.21

5.08

2.7

2.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

178

2.21

5.07

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.29

5.02

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

100

2.62

4.89

2.9

2.3

1.93

1.87

umol/l

0.14

(4015189) Microbial culture of sputum

3.49

4.89

3.3

2.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

481

1.71

4.89

2.7

2.3

127.88

130.37

g/l

0.41

387

(3052592) Norovirus Ag [Presence] in Stool

4.57

4.86

1.3

1.5

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

7.72

4.85

1.0

0.04

0.03

u/ml

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.00

4.83

1.2

—

(40768441) Liver Pathology biopsy report

156

2.26

4.82

1.8

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

117

767

1.55

4.77

1.6

1.7

10.64

12.94

u/ml

0.37

178

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.65

4.65

2.5

2.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

3.12

4.64

1.4

1.2

42.34

39.55

g/l

0.35

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.22

4.61

1.2

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

5.48

4.60

2.5

1.6

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

166

2.19

4.59

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

186

2.11

4.58

1.3

1.1

111.67

110.36

pmol/l

0.06

186

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.62

4.56

1.2

4.0

61.58

75.02

mg/l

0.36

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

193

2.09

4.56

1.1

—

(3024932) HLA-DR beta [Type]

2.98

4.55

1.2

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

2.73

4.51

3.7

2.5

9.01

9.52

mg/l

0.14

(40768795) Lymph node Pathology biopsy report

194

2.08

4.50

1.4

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.16

4.48

1.2

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

607

1.59

4.35

2.2

2.0

5.60

13.04

iu/l

0.38

256

(40757494) Bilirubin.total [Moles/volume] in Blood

2.67

4.32

2.5

1.7

15.90

34.71

umol/l

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.67

4.32

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.02

4.31

1.3

—

(4268621) Lupus anticoagulant assay

225

1.97

4.31

2.1

2.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

158

2.17

4.28

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

158

2.17

4.28

1.2

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

114

2.38

4.23

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

556

1.60

4.23

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

395

1.72

4.20

1.3

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

396

1.71

4.16

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

161

2.13

4.10

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

116

2.34

4.08

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

280

1.84

4.07

1.7

1.5

454.19

358.79

mu/l

0.49

215

(3002079) Sodium [Moles/time] in 24 hour Urine

2.51

4.05

1.4

1.3

150.65

165.04

mmol/24h

0.44

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.35

4.04

1.4

2.5

13.29

5.07

ug/l

0.45

(3004716) Salmonella sp identified in Stool by Organism specific culture

157

1133

1.41

4.01

1.5

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

341

1.75

3.98

1.3

49.58

38.06

u/l

0.22

287

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.83

3.95

3.3

2.7

0.60

0.62

mmol/l

0.40

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.73

3.92

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.98

3.85

1.2

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

5.28

3.82

1.6

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.07

3.80

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.49

3.80

1.6

2.0

117.63

124.32

umol/l

—

(3044927) Protein electrophoresis panel - Urine

187

1.99

3.78

1.3

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

160

2.08

3.77

1.1

1.0

238.84

253.92

mg/l

0.15

139

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.60

3.74

1.2

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.92

3.73

3.1

2.7

4.82

4.83

kpa

0.01

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.92

3.73

3.1

2.7

10.28

9.96

kpa

0.22

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

3.60

3.69

1.0

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

109

2.31

3.69

1.6

1.5

9.04

6.87

u/l

0.26

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

169

2.03

3.64

1.2

1.1

38.36

41.02

mg/l

0.12

139

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

106

725

1.48

3.62

4.2

3.4

4504.58

856.77

u/ml

0.44

626

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.42

3.62

1.3

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

322

1.72

3.58

1.3

4.00

4.86

u/ml

0.25

145

(3017446) Testosterone [Moles/volume] in Serum or Plasma

197

1507

1.33

3.54

2.2

2.3

11.41

12.42

nmol/l

0.93

180

1358

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

5.31

3.51

3.8

2.5

2.83

2.84

mg/l

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

106

2.28

3.45

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

296

1.74

3.44

2.3

2.9

3.85

152.76

u/ml

0.58

291

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.56

3.43

1.0

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.56

3.43

1.2

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

3.76

3.38

5.5

3.8

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

154

2.03

3.35

1.4

1.1

—

(4024509) Urine culture

129

931

1.41

3.34

2.1

1.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

132

957

1.40

3.33

2.4

2.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

211

1.86

3.31

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

8.59

3.26

2.2

2.1

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

8.59

3.26

1.5

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1971

18986

1.21

3.25

5.8

4.8

5.91

5.86

mmol/l

0.85

1816

17522

(3019174) dRVVT (LA screen)

4.75

3.23

1.3

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

4.75

3.23

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.45

3.21

1.6

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

222

1.82

3.15

2.7

2.4

21.75

22.59

mg/l

0.06

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1922

18485

1.20

3.14

4.7

4.0

1.33

1.26

mmol/l

4.36

1779

17123

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.63

3.13

1.1

1.0

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

2.26

3.13

2.9

2.3

32.08

28.63

umol/l

0.79

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

173

1.92

3.09

1.2

1.3

134.00

257.19

titre

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.81

3.08

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.01

3.08

1.2

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.23

3.06

1.2

988.89

1033.33

titre

—

(40765096) Chromosome analysis panel by Banding

2.59

3.04

1.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1796

17191

1.18

3.02

33.2

18.2

13.83

13.54

16.27

1785

16956

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

144

1083

1.35

2.94

3.1

2.3

1566.75

5913.99

u/l

3.35

442

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

184

1.86

2.92

7.5

3.4

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

4.72

2.92

1.6

1.1

13.15

28.03

u/l

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

156

1.93

2.90

1.2

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.71

2.88

1.0

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

5.40

2.87

1.4

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.68

2.87

5.8

2.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.26

2.87

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

3.17

2.85

2.0

1.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.17

2.85

1.9

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

157

1204

1.33

2.82

1.0

—

(3049717) Cytology report of Urine Cyto stain

639

1.44

2.79

2.1

2.6

—

(3010813) Leukocytes [#/volume] in Blood

2252

22079

1.32

2.76

43.2

22.4

6.99

6.68

e9/l

4.31

2222

21585

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

124

2.03

2.76

1.3

1.1

1731.68

1424.05

miu/ml

0.55

124

(3007461) Platelets [#/volume] in Blood

2251

22068

1.32

2.76

43.2

22.4

256.17

253.55

e9/l

0.99

2225

21641

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

152

1.92

2.75

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

8.35

2.75

1.0

0.03

0.02

u/ml

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

188

1.82

2.75

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

343

2902

1.21

2.71

2.4

2.2

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2251

22074

1.31

2.70

42.9

22.3

91.18

90.73

4.58

2235

21861

(3035941) MCH [Entitic mass]

2251

22076

1.31

2.68

42.9

22.3

30.27

30.22

0.69

2236

21862

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2251

22076

1.31

2.68

43.9

22.8

39.71

40.41

2.70

2235

21851

(3026361) Erythrocytes [#/volume] in Blood

2251

22077

1.31

2.67

43.0

22.4

4.38

4.49

e12/l

18.68

2224

21588

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.80

2.64

1.5

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

228

1.72

2.63

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

2.40

2.63

1.1

1.0

22.28

11.21

u/ml

—

(3004775) Volume in Urine collected for unspecified duration

141

1.93

2.60

3.2

2.3

646.25

618.89

0.14

(4027681) Cerebrospinal fluid IgG ratio and IgG index

134

1.95

2.60

1.3

1.2

0.60

ratio

0.00

(3000963) Hemoglobin [Mass/volume] in Blood

2251

22086

1.30

2.59

43.4

22.6

131.67

134.68

g/l

18.49

2237

21872

(3020191) Ethanol [Moles/volume] in Serum or Plasma

170

1.83

2.59

2.1

1.4

0.64

1.31

promille

1.79

135

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.19

2.57

1.1

185.75

208.29

iu/ml

0.17

(3003694) ABO and Rh group [Type] in Blood

706

6372

1.15

2.57

1.6

1.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.06

2.56

2.3

2.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

7.15

2.55

1.8

5.6

—

(3033086) Enterovirus Ab [Titer] in Serum

7.15

2.55

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.51

2.53

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.82

2.46

1.3

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

151

1180

1.30

2.41

1.6

1.4

25.12

25.09

iu/l

0.00

133

990

(3026480) Teichoate Ab [Titer] in Serum

6.26

2.37

1.2

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

6.26

2.37

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.64

2.36

1.4

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

125

1.93

2.35

1.2

1.06

ratio

0.13

105

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.83

2.34

2.3

2.1

—

(40758292) HTLV I+II Ab panel - Serum

2.83

2.34

1.4

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

2.10

2.33

1.1

96.85

91.59

0.30

(3013139) Helicobacter pylori Ag [Presence] in Stool

174

1393

1.27

2.31

1.2

1.3

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

3.22

2.30

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.46

2.27

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.46

2.27

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.46

2.27

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.46

2.27

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.23

2.27

1.8

1.5

16.03

14.46

pmol/l

0.47

(4195642) Thrombophilia screening test

302

1.57

2.25

1.3

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

326

2797

1.19

2.23

2.0

1.8

—

(3046861) Legionella sp Ag [Presence] in Urine

5.56

2.21

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

417

1.47

2.21

3.5

2.4

88.54

97.26

ug/min

0.08

256

(3027923) C peptide [Moles/volume] in Serum or Plasma

121

1.91

2.20

1.7

1.5

1.52

1.31

nmol/l

0.26

(3004451) EKG impression Narrative

107

1.97

2.20

1.1

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

241

1.63

2.19

1.5

1.3

1182.09

1665.35

e6/l

0.63

171

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.51

2.18

1.1

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

309

2645

1.19

2.18

1.6

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.25

2.17

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

4.29

2.15

7.3

4.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

4.29

2.15

1.8

8.4

—

(3024869) Neuronal Ab [Presence] in Serum

3.01

2.14

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

362

3146

1.18

2.14

2.5

2.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

260

1.59

2.09

1.5

1.3

0.16

0.25

nmol/l

0.64

199

(3042517) Benzodiazepines panel - Urine

3.21

2.09

3.9

2.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

111

850

1.32

2.09

1.5

1.3

236.55

232.64

miu/ml

0.03

416

(3018333) Ribosomal P Ab [Presence] in Serum

153

1.77

2.08

1.3

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.91

2.07

1.1

1.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

5.01

2.07

1.2

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.01

2.04

1.5

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

116

898

1.31

2.03

2.0

1.7

360.42

299.30

mu/l

0.98

110

816

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.41

2.02

1.5

8.92

8.64

ug/l

0.09

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.11

2.02

1.1

83.43

90.54

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

533

4793

1.14

2.00

5.7

5.4

2.31

2.99

ug/l

0.93

470

4313

(3002256) Pathology report gross observation

314

2713

1.18

2.00

1.3

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.82

2.00

6.8

3.6

—

(3045788) Cell count panel - Pleural fluid

201

1.65

1.99

1.5

1.3

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

105

1.91

1.95

1.3

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.55

1.94

3.0

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

204

1.63

1.89

1.1

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

3.19

1.88

1.0

2.77

7.42

u/ml

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

409

1.43

1.84

1.1

9.05

18.38

au/ml

0.80

111

(3028707) Methadone [Presence] in Urine by Screen method

460

1.40

1.83

2.3

3.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

4.17

1.82

1.0

1.2

—

(21494755) Public health laboratory ask at order entry panel

162

1965

0.81

1.82

1.4

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2008

19593

1.15

1.81

5.5

4.8

4.58

4.64

mmol/l

2.27

1881

18433

(4211845) Urine protein measurement

101

1.89

1.80

3.0

2.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.27

1.80

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

320

1.48

1.79

1.2

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2.03

1.75

3.5

1.9

42.51

40.17

g/l

1.06

(40757373) Influenza virus identified in Isolate

2.51

1.74

2.1

1.8

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

339

1.45

1.73

2.1

2.7

6.90

5.91

umol/l

0.13

243

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

566

0.67

1.73

1.6

65.81

59.14

ug/l

0.46

566

(3051611) Lipemic interference index of Serum or Plasma

186

1.62

1.72

3.6

3.5

12.67

12.55

index

0.02

106

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.92

1.72

1.0

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

315

1.47

1.71

1.2

1.1

129.87

116.91

1.65

289

(3028308) Erythrocytes [#/volume] in Pleural fluid

202

1.59

1.71

1.6

1.3

17898.76

83063.75

e6/l

0.97

111

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

753

1.30

1.71

2.0

1.9

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.51

1.66

1.4

1.3

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.10

1.65

1.1

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.81

1.65

3.0

4.9

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.93

1.64

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.98

1.64

1.1

78.33

89.83

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

2.21

1.57

3.3

5.5

11.91

8.02

0.61

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.21

1.57

1.6

2.8

31.09

47.90

1.78

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

100

790

1.28

1.56

2.5

1.8

4.28

3.91

mg/l

0.21

577

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

339

1.42

1.55

1.1

2.74

2.54

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.04

1.54

1.2

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

123

1.71

1.50

7.6

7.9

680.20

164.11

ug/l

0.34

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

2.86

1.50

1.0

—

50.75

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.86

1.50

1.2

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

131

1.69

1.49

1.2

1.0

1.01

1.06

u/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

334

1.42

1.48

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.44

1.48

2.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.44

1.48

2.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.44

1.48

2.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.50

1.45

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1990

19473

1.13

1.45

5.4

4.7

1.43

1.47

mmol/l

4.40

1852

18210

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.73

1.43

4.5

9.6

5.82

mmol/l

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.73

1.43

1.2

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2025

19844

1.13

1.41

6.0

5.4

2.68

2.72

mmol/l

1.26

1890

18581

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

415

1.36

1.40

3.6

2.4

1.10

0.83

nmol/l

1.41

354

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

769

0.75

1.39

1.1

0.75

0.65

ratio

—

(3024928) Oxygen saturation in Venous blood

538

1.31

1.37

2.9

3.6

59.03

61.21

0.30

525

(3011288) Drugs identified in Urine by Screen method Nominal

760

1.26

1.37

3.0

3.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.20

1.37

6.4

6.0

7.06

5.42

kpa

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.61

1.36

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

258

1.44

1.31

1.6

1.3

—

nmol/l

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.50

1.30

1.5

1.0

—

(44806071) Cardiolipin IgM antibody measurement

2.50

1.30

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

816

0.77

1.30

1.1

1.49

1.54

g/l

1.06

816

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

352

1.37

1.29

1.3

1.1

60.15

1631.10

iu/ml

0.52

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

882

8341

1.09

1.27

2.1

1.9

1.42

1.34

mmol/l

1.92

723

7109

(3023410) Appearance of Cerebral spinal fluid

235

1.45

1.27

2.2

1.9

—

(3012441) Differential panel - Pleural fluid

194

1.50

1.27

1.6

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

294

1.40

1.26

1.1

1.33

2.65

eliau/ml

1.72

135

(3016879) Cocaine [Presence] in Urine

122

1016

1.21

1.24

2.4

2.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.86

1.24

1.7

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.86

1.24

1.6

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

640

0.74

1.23

1.6

1.8

—

(3017569) Oxygen content in Arterial blood

108

1.67

1.22

2.4

2.6

14.84

16.13

0.62

108

(3006462) Nitrate [Presence] in Urine

1.73

1.21

3.4

2.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

419

3833

1.11

1.20

4.5

4.4

22.10

21.67

0.20

218

1844

(3027008) Opiates [Presence] in Urine

130

1096

1.20

1.18

2.3

2.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

325

1.36

1.16

1.3

1.2

2.65

4.02

u/ml

0.59

118

(3047007) Chlamydophila sp Ab [Presence] in Serum

351

1.35

1.16

1.1

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.50

1.15

2.2

1.4

63.80

48.60

umol/l

—

(3000330) Specific gravity of Urine by Test strip

121

1018

1.20

1.13

4.6

3.3

1.02

ratio

0.56

111

920

(3028300) Cannabinoids [Presence] in Urine

130

1101

1.19

1.13

2.3

2.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

817

1.22

1.13

1.7

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

175

1.49

1.12

1.0

1.1

20.63

15.31

u/ml

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

103

1.66

1.12

1.7

2.4

51.57

52.20

umol/l

0.01

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

167

1.50

1.12

1.7

2.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

122

1438

0.84

1.10

1.6

992.30

1007.51

mu/l

0.07

101

1223

(3041672) Baker's yeast Ab [Presence] in Serum

2.38

1.09

1.0

1.2

—

(3005570) Glucose [Moles/volume] in Urine

218

1.43

1.09

1.7

2.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

112

1.61

1.08

1.3

1.2

14.22

8.79

mm/h

0.88

112

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

382

1.32

1.07

1.4

5.48

4.22

ug/l

0.24

350

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.65

1.06

1.1

1.2

—

(3022621) pH of Urine by Test strip

194

1707

1.15

1.06

2.3

2.6

6.06

6.11

0.26

122

1153

(3000764) Benzodiazepines [Presence] in Urine

128

1090

1.18

1.06

2.4

2.2

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

155

1783

0.86

1.05

1.5

1.6

3.41

3.48

mmol/l

0.27

1198

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

212

1.42

1.04

6.1

5.4

42.90

67.27

u/ml

0.28

(40768806) Pleura Pathology biopsy report

187

1.45

1.03

1.8

1.6

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

1.96

1.03

1.6

1.1

47.27

56.66

—

(4146454) Self-monitoring of blood glucose

204

1.43

1.03

2.4

2.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

697

0.78

1.01

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

104

874

1.20

1.01

2.3

2.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.18

0.98

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.18

0.98

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

442

1.27

0.97

5.7

4.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.89

0.94

1.1

1.6

1.17

1.18

mmol/l

—

(3027944) Amphetamines [Presence] in Urine

126

1086

1.17

0.93

2.4

2.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

175

1.43

0.93

1.0

1.1

10.61

9.87

iu/ml

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

374

1.29

0.92

4.0

3.6

0.78

0.80

nmol/l

0.14

306

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.15

0.91

1.8

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

118

1.53

0.90

2.6

1.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

254

0.67

0.89

1.4

1.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.91

0.88

1.8

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

2.00

0.87

1.5

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

128

1.49

0.86

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

260

2369

1.11

0.85

1.7

1.8

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

112

1.52

0.85

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.94

0.84

2.3

1.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.94

0.84

1.2

1.4

—

(3020491) Glucose [Moles/volume] in Blood

146

1.44

0.82

4.0

1.6

5.80

6.61

mmol/l

0.76

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.88

0.81

1.3

1.1

—

(3024263) Appearance of Synovial fluid

1.58

0.81

1.6

—

(44806420) Estimation of glomerular filtration rate

234

1.33

0.77

3.2

2.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

323

1.27

0.76

1.3

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

840

0.84

0.73

1.4

1.2

0.88

0.89

g/l

0.06

840

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

215

2356

0.90

0.73

1.7

1.9

3.34

3.46

ratio

0.75

149

1760

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.62

0.71

1.9

2.6

146.83

122.10

ng/l

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.58

0.71

1.8

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.75

0.71

1.0

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

110

1.46

0.68

2.3

1.9

104.25

113.86

ng/l

0.24

110

(3025018) Bordetella pertussis Ab [Titer] in Serum

170

1.36

0.67

1.1

1.2

—

(3014891) Appearance of Pleural fluid

1.79

0.66

2.2

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.79

0.66

4.4

7.0

10.34

11.29

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

398

3745

1.08

0.66

1.7

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

307

2862

1.08

0.65

3.3

3.2

0.72

0.78

ug/l

0.44

215

1804

(4198724) Urine methamphetamine measurement

103

1.46

0.65

1.9

2.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

924

0.86

0.64

1.5

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

179

1632

1.10

0.62

2.3

2.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.67

0.61

1.6

1.4

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.67

0.61

3.4

1.6

1.22

1.31

umol/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

401

0.80

0.61

1.5

1.3

—

(40768793) Breast Pathology biopsy report

527

1.18

0.60

1.4

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.00

0.60

0.0

3.5

—

0.20

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.54

0.59

1.0

19.79

37.04

iu/ml

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.53

0.59

1.3

1.5

41.09

169.14

nmol/24h

0.83

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

149

1.35

0.57

1.5

2.3

1.13

1.96

u/field

0.84

(3006653) Thiamine [Moles/volume] in Blood

115

1.39

0.56

1.3

139.69

138.18

nmol/l

0.04

115

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

125

0.64

0.54

1.1

1.5

5.16

5.76

mmol/l

—

119

(3005033) Fetal Nuchal fold Thickness US

588

0.85

0.53

1.5

1.20

1.29

0.86

415

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

397

1.19

0.51

1.5

0.23

0.39

nmol/l

2.56

315

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.46

0.50

2.0

1.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

171

1.29

0.49

1.4

1.9

—

(3036782) Glucose [Moles/volume] in Pleural fluid

198

1.27

0.49

1.4

1.3

6.92

6.47

mmol/l

0.30

188

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

345

0.81

0.49

1.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.46

0.46

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

601

0.86

0.46

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

611

0.86

0.46

1.5

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.43

0.45

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

1.38

0.41

1.4

1.9

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

105

1.34

0.41

1.3

168.49

161.65

pmol/l

0.06

105

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

243

1.20

0.37

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

553

1.12

0.37

1.4

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

143

1.26

0.37

1.6

1.5

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.43

0.35

1.2

1.4

2.80

4.79

nmol/l

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

208

1970

1.06

0.34

2.5

2.2

—

(3002619) Bacteria identified in Specimen by Culture

1.33

0.33

2.3

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

435

0.87

0.33

4.3

3.4

19.77

25.35

mg/l

0.91

296

(3013247) Albumin in CSF/Albumin in Serum or Plasma

1.28

0.32

1.0

5.55

6.57

mg/g

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

282

0.85

0.30

1.2

1.4

6.61

7.22

mmol/l

0.84

251

(3034426) Prothrombin time (PT)

1.29

0.28

1.3

26.75

28.11

—

(3022689) Creatine [Moles/volume] in Urine

1.27

0.27

2.4

1.6

6.76

7.95

mmol/l

—

(1002224) Polysomnography panel

105

981

1.07

0.27

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

116

0.77

0.27

1.9

1.5

0.73

0.47

e9/l

—

116

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

182

0.82

0.26

1.5

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

790

0.92

0.26

1.5

72.64

59.53

ug/l

0.98

665

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

404

0.89

0.25

2.4

1.8

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

714

0.92

0.24

1.5

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1714

17273

0.97

0.24

33.7

18.7

331.67

332.34

g/l

2.22

1701

17171

(4281824) Cell count and differential, peritoneal fluid

228

1.14

0.22

1.2

1.1

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.5

—

0.14

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

118

1.19

0.19

1.7

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

118

1.19

0.19

2.5

2.3

7.56

8.65

mmol/l

0.81

118

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

724

0.94

0.18

1.6

1.5

1.31

1.17

ratio

0.54

433

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

724

0.94

0.18

1.6

1.5

1.26

1.10

ratio

0.59

429

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

724

0.94

0.18

1.6

1.5

0.91

0.96

ratio

0.84

429

(3029396) Erythrocyte agglutination [Presence] in Blood

1.21

0.18

2.3

3.3

—

(3025130) Human papilloma virus identified in Specimen

383

0.91

0.18

1.7

1.9

—

(1617658) Protocol used for examination of sentinel lymph nodes

173

0.87

0.16

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.14

0.16

3.5

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.17

0.13

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

109

0.83

0.13

1.2

1.1

—

(1761868) Lipid panel - Serum or Plasma

791

7989

0.99

0.12

3.4

2.9

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

134

1.12

0.11

1.1

1.0

729.70

727.16

ng/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

116

1129

1.03

0.09

1.8

1.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

136

1.10

0.08

1.1

1.0

25.60

42.23

ng/l

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

0.82

0.08

1.2

1.4

0.60

3.27

—

(4094501) Cardiovascular stress test using bicycle ergometer

508

0.96

0.06

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

129

1.09

0.05

1.2

1.5

77.57

79.97

umol/l

0.17

129

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

732

1.01

0.01

1.5

—

(40768800) Prostate Pathology biopsy report

316

0.98

0.00

1.0

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

205

0.98

0.00

1.3

1.6

7.42

7.63

mmol/l

0.18

199

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

2.0

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

2.8

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

-0.00

0.0

1.0

—

36.46

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.93

-0.00

2.6

2.0

143.63

152.20

nmol/l

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

5.8

—

0.24

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

6.4

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

382.60

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.96

-0.00

1.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

2800.00

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.0

—

71.74

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

26.10

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3020650) Glucose [Presence] in Urine

0.97

-0.00

1.1

1.7

0.00

estimate

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

231.86

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: L12_INTERNALSUBSTANCEDERM – Dermatitis due to substances taken internally

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Dermatitis due to substances taken internally

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Dermatitis due to substances taken internally (L12_INTERNALSUBSTANCEDERM)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints